Drugs, Treatment and Vaccines


Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2

Thakur A, Tan SPF, Chan JCY.

Abstract:

Link to Article

Stem Cell Therapy for Covid-19: Possibilities and Challenges

Choudhery MS, Harris DT.

Abstract:

Link to Article

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells

Ko M, Jeon S, Ryu WS, Kim S.

Abstract:

Link to Article

Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy

Salvarani C, Mancuso P, Gradellini F, Viani N, Pandolfi P, Reta M, Carrozzi G, Sandri G, Bajocchi G, Elena G, Muratore F, Boiardi L, Pipitone N, Cassone G, Croci S, Marata AM, Costantini M, Giorgi Rossi P.

Abstract:

Link to Article

Biologic drugs during COVID-19 outbreak

Montesu MA, Biondi G, Sotgiu G, Sucato F, Satta R.

Abstract:

Link to Article

Climate and COVID-19 pandemic: effect of heat and humidity on the incidence and mortality in world's top ten hottest and top ten coldest countries

Meo SA, Abukhalaf AA, Alomar AA, Al-Beeshi IZ, Alhowikan A, Shafi KM, Meo AS, Usmani AM, Akram J.

Abstract:

Link to Article

Association between the spread of COVID-19 and weather-climatic parameters

Carta MG, Scano A, Lindert J, Bonanno S, Rinaldi L, Fais S, Orr√π G.

Abstract:

Link to Article

Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy

De Giorgi A, Fabbian F, Di Simone E, Greco S, De Giorgio R, Zuliani G, Passaro A, Caselli E, Manfredini R; OUTCOME-INTMED-COV19 Study Collaborators.

Abstract:

Link to Article

Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence

Ren HW, Wu Y, Dong JH, An WM, Yan T, Liu Y, Liu CC.

Abstract:

Link to Article

Hospital reengineering against COVID-19 outbreak: 1-month experience of an Italian tertiary care center

Tosoni A, Rizzatti G, Nicolotti N, Di Giambenedetto S, Addolorato G, Franceschi F, Zileri Dal Verme L; Gemelli Against COVID-19 Clinician Team (GAC-19 CT) Study Group.

Abstract:

Link to Article

Corticosteroid therapy for patients with severe novel Coronavirus disease 2019

Ma Q, Qi D, Deng XY, Yuan GD, Tian WG, Cui Y, Yan XF, Wang DX.

Abstract:

Link to Article

Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?

Orr√π B, Szekeres-Bartho J, Bizzarri M, Spiga AM, Unfer V.

Abstract:

Link to Article

Psychological support and the COVID-19 - A short report

Chen GF, Cheng YR, Ye L, Wang MW, Zhou MY, Zhang F, Chen J, Feng ZH.

Abstract:

Link to Article

Speculative clues on Myasthenia gravis and COVID-19

Scoppetta C, Casciato S, Di Gennaro G.

Abstract:

Link to Article

Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)

Dar SA, Wahid M, Haque S, Almalki SS, Akhter N.

Abstract:

Link to Article

Unwavering Regulatory Safeguards for COVID-19 Vaccines

Shah A, Marks PW, Hahn SM.

Abstract:

Link to Article

Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

Mégarbane B, Scherrmann JM.

Abstract:

Link to Article

Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study

Kewan T, Covut F, Al-Jaghbeer MJ, Rose L, Gopalakrishna KV, Akbik B.

Abstract:

Link to Article

Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report

Carannante N, Fiorentino G, Corcione A, Di Sarno R, Spatarella M, Maturo N, Fragranza F, Di Micco P.

Abstract:

Link to Article

Home-based traditional Chinese medicine nursing interventions for discharged patients with COVID-19: a rapid review of Chinese guidelines

Xu X, Shi YN, Wang RY, Liu T, Xu J, Mao W, Sun QH.

Abstract:

Link to Article

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review

Jeong GU, Song H, Yoon GY, Kim D, Kwon YC.

Abstract:

Link to Article

Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?

Calderone A, Menichetti F, Santini F, Colangelo L, Lucenteforte E, Calderone V.

Abstract:

Link to Article

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomi

Huang YQ, Tang SQ, Xu XL, Zeng YM, He XQ, Li Y, Harypursat V, Lu YQ, Wan Y, Zhang L, Sun QZ, Sun NN, Wang GX, Yang ZP, Chen YK.

Abstract:

Link to Article

Postulated Adjuvant Therapeutic Strategies for COVID-19

Ferreira AO, Polonini HC, Dijkers ECF.

Abstract:

Link to Article

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19

Norinder U, Tuck A, Norgren K, Munic Kos V.

Abstract:

Link to Article

Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study

Kalligeros M, Shehadeh F, Atalla E, Mylona EK, Aung S, Pandita A, Larkin J, Sanchez M, Touzard-Romo F, Brotherton A, Shah R, Cunha CB, Mylonakis E.

Abstract:

Link to Article

Medication shortages during the COVID-19 pandemic: Saving more than COVID lives

Sen-Crowe B, McKenney M, Elkbuli A.

Abstract:

Link to Article

Are BCG-induced non-specific effects adequate to provide protection against COVID-19?

Vashishtha VM.

Abstract:

Link to Article

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin

Anupama BK, Adhikari S, Chaudhuri D.

Abstract:

Link to Article

Response to "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated with COVID-19: A Theoretical Hypothesis and Early Clinical Experience"

Burger AM, D'Agostini M.

Abstract:

Link to Article

Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Gouda AS, Mégarbane B.

Abstract:

Link to Article

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase

Xu Y, Jiang H.

Abstract:

Link to Article

Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C, Ye P, Chen X, Wang B, Xu Z, Zhang Q, Xu X, Gao H, Wu X, Li D, Jiang W, Qu J, Xiang C, Li L.

Abstract:

Link to Article

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Yu B, Li C, Chen P, Li J, Jiang H, Wang DW.

Abstract:

Link to Article

Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope

Shankar A, Dubey A, Saini D, Prasad CP.

Abstract:

Link to Article

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation

Wang J, Peng Y, Xu H, Cui Z, Williams RO 3rd.

Abstract:

Link to Article

COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

Stauffer WM, Alpern JD, Walker PF.

Abstract:

Link to Article

Glucocorticoids save lives in COVID-19 patients

Deng CX.

Abstract:

Link to Article

We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?

Kersten DJ, Makaryus AN.

Abstract:

Link to Article

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels

Xiang Z, Liu J, Shi D, Chen W, Li J, Yan R, Bi Y, Hu W, Zhu Z, Yu Y, Yang Z.

Abstract:

Link to Article

COVID vaccine results pour in

Abstract:

Link to Article

Anti-IL-6Rs falter in COVID-19

Mullard A.

Abstract:

Link to Article

COVID-19 vaccine guidelines

Mullard A.

Abstract:

Link to Article

Hydroxychloroquine is no miracle cure for covid-19 infection -imaging and clinical course in an elderly female

Harsch IA, Skiba M, Lopatta E, Konturek PC.

Abstract:

Link to Article

Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production

Fintelman-Rodrigues N, Sacramento CQ, Ribeiro Lima C, Souza da Silva F, Ferreira AC, Mattos M, de Freitas CS, Cardoso Soares V, da Silva Gomes Dias S, Temerozo JR, Miranda MD, Matos AR, Bozza FA, Carels N, Alves CR, Siqueira MM, Bozza PT, Souza TML.

Abstract:

Link to Article

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

Ugarte-Gil MF, Konig MF, Korsten P, Berenbaum F, Kim AH, Sparks JA.

Abstract:

Link to Article

COVID-19: pharmacology and kinetics of viral clearance

Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, Manfredi AA, Rovere-Querini P.

Abstract:

Link to Article

Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication

Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH.

Abstract:

Link to Article

Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers

Voinsky I, Gurwitz D.

Abstract:

Link to Article

Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development

Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K.

Abstract:

Link to Article

COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?

Thangaraju P, Gurunthalingam MP, Varthya S, Venkatesan S, Thangaraju E.

Abstract:

Link to Article

The use of dexamethasone in the treatment of COVID-19

Lester M, Sahin A, Pasyar A.

Abstract:

Link to Article

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro

Clementi N, Criscuolo E, Diotti RA, Ferrarese R, Castelli M, Dagna L, Burioni R, Clementi M, Mancini N.

Abstract:

Link to Article

Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection

Voisin O, Lorc'h EL, Mahé A, Azria P, Borie MF, Hubert S, Ménage E, Guillerm JC, Mourad JJ.

Abstract:

Link to Article

Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis

Pei L, Zhang S, Huang L, Geng X, Ma L, Jiang W, Li W, Chen D.

Abstract:

Link to Article

[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness]

Vollaard A, Gieling EM, van der Linden PD, Sinha B, de Boer MGJ.

Abstract:

Link to Article

Dexamethasone nanomedicines for COVID-19

Lammers T, Sofias AM, van der Meel R, Schiffelers R, Storm G, Tacke F, Koschmieder S, Brümmendorf TH, Kiessling F, Metselaar JM.

Abstract:

Link to Article

A Sound Approach: Hydroxychloroquine Reduces Mortality in Severe COVID-19

Zervos M, Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, Brar I, Alangaden GJ, Ramesh MS, McKinnon JE, O'Neill W.

Abstract:

Link to Article

Medical education focus in published articles related to COVID-19

Aggarwal G, Aggarwal S, Robles J, Depasquale JR, Auseon A.

Abstract:

Link to Article

Transmission mode associated with coronavirus disease 2019: a review

Vella F, Senia P, Ceccarelli M, Vitale E, Maltezou H, Taibi R, Lleshi A, Venanzi Rullo E, Pellicanò GF, Rapisarda V, Nunnari G, Ledda C.

Abstract:

Link to Article

An emergency strategy for intensive care unit during COVID-19 outbreak in Chongqing, China

Deng W, Qi D, Wang DX.

Abstract:

Link to Article

SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential

Rat P, Olivier E, Dutot M.

Abstract:

Link to Article

The impact of COVID-19 on doctors' well-being: results of a web survey during the lockdown in Italy

De Sio S, Buomprisco G, La Torre G, Lapteva E, Perri R, Greco E, Mucci N, Cedrone F.

Abstract:

Link to Article

Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy

De Vito A, Geremia N, Fiore V, Princic E, Babudieri S, Madeddu G.

Abstract:

Link to Article

Severe COVID-19 patients with liver injury: a seven-case series

Li X, Zhang ZC, Zhang PL.

Abstract:

Link to Article

Breast surgeons updating on the thresholds of COVID-19 era: results of a multicenter collaborative study evaluating the role of online videos and multimedia sources on breast surgeons education and training

Marcasciano M, Kaciulyte J, Mori FLR, Lo Torto F, Barellini L, Loreti A, Fanelli B, De Vita R, Redi U, Marcasciano F, Di Cesare F, Dal Prà G, Conversi A, Elia L, Montemari G, Vaia N, Bernini M, Sordi S, Luridiana G, D'Ermo G, Monti M, De Luca A, Ricci F, Mazzocchi M, Gentilucci M, Greco M, Losco L, Valdatta LA, Raposio E, Giudice G, Maruccia M, Di Benedetto G, Cigna E, Casella D, Ribuffo D.

Abstract:

Link to Article

Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors

Ranjbar A, Jamshidi M, Torabi S.

Abstract:

Link to Article

Clinical characteristics and outcomes of 2019-nCoV-infected patients admitted at different time periods

Liu WR, Zuo GJ, Qin Y.

Abstract:

Link to Article

From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality

Abbasi Pashaki P, Habibi Roudkenar M, Rahim F, Ebrahimi A.

Abstract:

Link to Article

Clinical outcomes of 201 neonates born to mothers with COVID-19: a systematic review

Yoon SH, Kang JM, Ahn JG.

Abstract:

Link to Article

Role of 5G-powered remote robotic ultrasound during the COVID-19 outbreak: insights from two cases

Yu RZ, Li YQ, Peng CZ, Ye RZ, He Q.

Abstract:

Link to Article

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

Lofgren SMM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanshi R, Schwartz IS, Silverman M, Chagla Z, Kelley LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R.

Abstract:

Link to Article

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W.

Abstract:

Link to Article

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Rayman G, Lumb AN, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney HC, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Abstract:

Link to Article

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

Morrisette T, Lodise TP, Scheetz MH, Goswami S, Pogue JM, Rybak MJ.

Abstract:

Link to Article

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19

Zou L, Dai L, Zhang X, Zhang Z, Zhang Z.

Abstract:

Link to Article

Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemia

Capucci A, Santarelli A, Bartolomei M, Paolizzi C, Biagetti C, Dappozzo A, Piovaccari G.

Abstract:

Link to Article

A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients

Gao G, Wang A, Wang S, Qian F, Chen M, Yu F, Zhang J, Wang X, Ma X, Zhao T, Zhang F, Chen Z.

Abstract:

Link to Article

Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19)

Ruamviboonsuk P, Lai TYY, Chang A, Lai CC, Mieler WF, Lam DSC.

Abstract:

Link to Article

A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population

Martinez Navarro W, Ly L, Segal MS, Shukla AM.

Abstract:

Link to Article

Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19

Wiwanitkit V.

Abstract:

Link to Article

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19

Mazzitelli M, Davoli C, Scaglione V, Fusco P, La Gamba V, Matera G, Trecarichi EM, Torti C.

Abstract:

Link to Article

Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: a systematic review and meta-analysis of 40 studies and 25,278 patients

Shao M, Li X, Liu F, Tian T, Luo J, Yang Y.

Abstract:

Link to Article

[Pharmacological treatment in uncertainty times: Hydroxychloroquine/chloroquine use in the COVID-19 treatment]

Mayayo-Vicente S, Rodriguez Salvanés F, Gallego-Arenas A, Sánchez-Gómez LM, Ruiz-López M, Sierra García B, Jurado-López A, Arriola-Bolado P, Cervera Cano M, Novella-Arribas B.

Abstract:

Link to Article

Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin and Combination in Patients Hospitalized with COVID-19"

Atkinson JG.

Abstract:

Link to Article

Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?

d'Arminio Monforte A, Tavelli A, Bai F, Marchetti G, Cozzi-Lepri A.

Abstract:

Link to Article

Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19

Rosenberg ES, Holtgrave DR, Udo T.

Abstract:

Link to Article

Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

Kara E, Demirkan K, Unal S.

Abstract:

Link to Article

In silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and their Potential Mechanisms of Action against SARS-CoV-2 Infection

Braz HLB, de Moraes Silveira JA, Marinho AD, de Moraes MEA, de Moraes Filho MO, Monteiro HSA, Jorge RJB.

Abstract:

Link to Article

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Teh CL, Cheong YK, Wan Musa WR, Wan Mohd Akbar SA, Mat Husin N, Gun SC.

Abstract:

Link to Article

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al

Mathian A, Amoura Z.

Abstract:

Link to Article

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial

Nanni O, Viale P, Vertogen B, Lilli C, Zingaretti C, Donati C, Masini C, Monti M, Serra P, Vespignani R, Grossi V, Biggeri A, Scarpi E, Galardi F, Bertoni L, Colamartini A, Falcini F, Altini M, Massa I, Gaggeri R, Martinelli G.

Abstract:

Link to Article

Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic

Husayn SS, Brown JD, Presley CL, Boghean K, Waller JD.

Abstract:

Link to Article

Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach

Rahman N, Ali F, Basharat Z, Shehroz M, Khan MK, Jeandet P, Nepovimova E, Kuca K, Khan H.

Abstract:

Link to Article

Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians

Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Humphrey LL.

Abstract:

Link to Article

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S.

Abstract:

Link to Article

Probing 3CL protease: Rationally designed chemical moieties for COVID-19

Sharma M, Prasher P, Mehta M, Zacconi FC, Singh Y, Kapoor DN, Dureja H, Pardhi DM, Tambuwala MM, Gupta G, Chellappan DK, Dua K, Satija S.

Abstract:

Link to Article

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial

Grau-Pujol B, Camprubí D, Marti-Soler H, Fernández-Pardos M, Guinovart C, Muñoz J.

Abstract:

Link to Article

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management

Lebin JA, LeSaint KT.

Abstract:

Link to Article

A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic

Scheetz MH, Konig MF, Robinson PC, Sparks JA, Kim AHJ.

Abstract:

Link to Article

Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings

Islam M.

Abstract:

Link to Article

Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?

Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S.

Abstract:

Link to Article

Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

Favalli EG, Ingegnoli F, Biggioggero M, Caporali R.

Abstract:

Link to Article

The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City

Maeda T, Obata R, Rizk DO D, Kuno T.

Abstract:

Link to Article

A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

Changeux JP, Amoura Z, Rey FA, Miyara M.

Abstract:

Link to Article

Non-pharmaceutical Interventions for Pandemic COVID-19: A Cross-Sectional Investigation of US General Public Beliefs, Attitudes, and Actions

Kantor BN, Kantor J.

Abstract:

Link to Article

Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression

Hu Z, Lv Y, Xu C, Sun W, Chen W, Peng Z, Chen C, Cui X, Jiao D, Cheng C, Chi Y, Wei H, Hu C, Zeng Y, Zhang X, Yi Y.

Abstract:

Link to Article

COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies

Singh JA, Ravinetto R.

Abstract:

Link to Article

COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning

Ong E, Wong MU, Huffman A, He Y.

Abstract:

Link to Article

Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment

Saldanha-Araujo F, Melgaço Garcez E, Silva-Carvalho AE, Carvalho JL.

Abstract:

Link to Article

While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?

Barrantes FJ.

Abstract:

Link to Article

Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study

Patel A, Shah K, Dharsandiya M, Patel K, Patel T, Patel M, Reljic T, Kumar A.

Abstract:

Link to Article

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM.

Abstract:

Link to Article

[Lipid treatment in the period COVID-19]

Frías Vargas M, Díaz Rodríguez A, Díaz Fernández B.

Abstract:

Link to Article

Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir

Brandariz-Nuñez D, Correas-Sanahuja M, Guarc E, Picón R, García B, Gil R.

Abstract:

Link to Article

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

Herrera-Lasso Reg√°s V, Dordal Culla MT, Lleonart Bellfill R.

Abstract:

Link to Article

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience

Jiménez-Brítez G, Ruiz P, Soler X.

Abstract:

Link to Article

Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection

Mansur JL, Tajer C, Mariani J, Inserra F, Ferder L, Manucha W.

Abstract:

Link to Article

Statins in COVID-19: is there any foundation?

Lima Martínez MM, Contreras MA, Marín W, D'Marco L.

Abstract:

Link to Article

Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19

Oronsky B, Knox S, Cabrales P, Oronsky A, Reid TR.

Abstract:

Link to Article

Clozapine and COVID-19

Silva E, Gee S, Smith S, Gaughran F.

Abstract:

Link to Article

Perspectives for the immune plasma treatment of COVID-19

Sayinalp B, Çinar OE, HaznedaroĞlu İC.

Abstract:

Link to Article

New Points of Departure for More Global Influenza Vaccine Use

Kiseleva I.

Abstract:

Link to Article

Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development

Ranga V, Niemelä E, Tamirat MZ, Eriksson JE, Airenne TT, Johnson MS.

Abstract:

Link to Article

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy

Drożdżal S, Rosik J, Lechowicz K, Machaj F, Kotfis K, Ghavami S, Łos MJ.

Abstract:

Link to Article

Therapeutic Cannabis and COVID-19: between opportunism and infoxication

Pascual Pastor F, Isorna Folgar M, Carvalho N, Carvalho F, Arias Horcajadas F.

Abstract:

Link to Article

Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study

Jeong HE, Lee H, Shin HJ, Choe YJ, Filion KB, Shin JY.

Abstract:

Link to Article

Pooling Data From Individual Clinical Trials in the COVID-19 Era

Petkova E, Antman EM, Troxel AB.

Abstract:

Link to Article

Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic

Gapud EJ, Kronbichler A, Gauckler P, Geetha D.

Abstract:

Link to Article

National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages

Piatek OI, Ning JC, Touchette DR.

Abstract:

Link to Article

COVID-19 and Drug Shortages: A Call to Action

Shuman AG, Fox ER, Unguru Y.

Abstract:

Link to Article

Non-Steroidal Anti-Inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review

Sodhi M, Khosrow-Khavar F, FitzGerald JM, Etminan M.

Abstract:

Link to Article

Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia

Abe T, Izumo T, Ueda A, Hayashi M, Ishibashi Y.

Abstract:

Link to Article

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine

Gies V, Bekaddour N, Dieudonné Y, Guffroy A, Frenger Q, Gros F, Rodero MP, Herbeuval JP, Korganow AS.

Abstract:

Link to Article

Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection

Wang Z, Yang L.

Abstract:

Link to Article

Democracy and Mobility: A Preliminary Analysis of Global Adherence to Non-Pharmaceutical Interventions for COVID-19

M Herren C, K Brownwright T, Y Liu E, El Amiri N, Majumder MS.

Abstract:

Link to Article

COVID-19: Urgent Reconsideration of Lung Edema as a Preventable Outcome: Inhibition of TRPV4 As a Promising and Feasible Approach

Kuebler W, Jordt SE, Liedtke W.

Abstract:

Link to Article

Computational search for potential COVID-19 drugs from FDAapproved drugs and small molecules of natural origin identifies several anti-virals and plant products

Sharma A, Tiwari V, Sowdhamini R.

Abstract:

Link to Article

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

Cortegiani A, Ippolito M, Greco M, Granone V, Protti A, Gregoretti C, Giarratano A, Einav S, Cecconi M.

Abstract:

Link to Article

The contribution of acute phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19)

Li L, Chen C.

Abstract:

Link to Article

Chloroquine as chemoprophylaxis for COVID-19: Will this work?

Abd-Elsalam S, Elkadeem M, Glal KA.

Abstract:

Link to Article

Chloroquine in fighting COVID-19: good, bad, or both?

Tang D, Li J, Zhang R, Kang R, Klionsky DJ.

Abstract:

Link to Article

Medication utilization in patients in New York hospitals during the COVID-19 pandemic

Dabestani A, DeAngelo D, Chhay SR, Larson BJ, Ganio MC.

Abstract:

Link to Article

Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies

Kala S, Dunk C, Acosta S, Serghides L.

Abstract:

Link to Article

Chloroquine for Covid 19: introducing drug repurposing to medical students

Koren G, Korn L.

Abstract:

Link to Article

Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study

Song T, Yuan S, Yuan Y, Chuangyan W, Jiuling C, Sihua W, Jinjun J.

Abstract:

Link to Article

Tocilizumab for severe COVID-19: a systematic review and meta-analysis

Lan SH, Lai CC, Huang HT, Chang SP, Lu LC, Hsueh PR.

Abstract:

Link to Article

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future

Zhang J, Wang M, Ding W, Wan J.

Abstract:

Link to Article

Blood nitrate and nitrite modulating nitric oxide bioavailability: potential therapeutic functions in COVID-19

Yamasaki H.

Abstract:

Link to Article

Propofol in COVID 19 - From basic science to clinical impact

Senthilkumaran S, Koushik M, Sanjay P, Thirumalaikolundusubramanian P.

Abstract:

Link to Article

Offline: Preparing for a vaccine against COVID-19

Horton R.

Abstract:

Link to Article

Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

Silva Arouche TD, Reis AF, Martins AY, S Costa JF, Carvalho Junior RN, J C Neto AM.

Abstract:

Link to Article

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

Poduri R, Joshi G, Jagadeesh G.

Abstract:

Link to Article

Radiation Therapy as a Treatment for COVID-19?

Kirsch DG.

Abstract:

Link to Article

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities

Manjaly Thomas ZR, Leuppi-Taegtmeyer A, Jamiolkowski D, Steveling-Klein E, Bellutti-Enders F, Hofmeier KS, Hartmann K.

Abstract:

Link to Article

Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2

Lisi L, Lacal PM, Barbaccia ML, Graziani G.

Abstract:

Link to Article

Micronutrients as immunomodulatory tools for COVID-19 management

Gasmi A, Tippairote T, Mujawdiya PK, Peana M, Menzel A, Dadar M, Benahmed AG, Bj√∏rklund G.

Abstract:

Link to Article

The minimal effect of zinc on the survival of hospitalized patients with Covid-19: an observational study

Yao JS, Paguio JA, Dee EC, Tan HC, Moulick A, Milazzo C, Jurado J, Della Penna N, Celi LA.

Abstract:

Link to Article

Potential Limitations of Plasmapheresis in Treatment of COVID-19 Patients and How to Overcome Them?

Daoud AM, Soliman KM, Ali HK.

Abstract:

Link to Article

COVID-19 and hydroxychloroquine: Let the available data speak for themselves

Paliani U, Cardona A.

Abstract:

Link to Article

Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications

Wei Y, Shah R.

Abstract:

Link to Article

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

Menegazzi M, Campagnari R, Bertoldi M, Crupi R, Di Paola R, Cuzzocrea S.

Abstract:

Link to Article

COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis

Fierabracci A, Arena A, Rossi P.

Abstract:

Link to Article

Evaluation of Current Therapies for COVID-19 Treatment

Sethi A, Bach H.

Abstract:

Link to Article

COVID-19: Mechanisms of Vaccination and Immunity

Speiser DE, Bachmann MF.

Abstract:

Link to Article

Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?

Berzal-Herranz A, Romero-López C.

Abstract:

Link to Article

Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Short Course Results

Ameri A, Rahnama N, Bozorgmehr R, Mokhtari M, Farahbakhsh M, Nabavi M, Shoaei SD, Izadi H, Yousefi Kashi AS, Dehbaneh HS, Taghizadeh-Hesary F.

Abstract:

Link to Article

Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-β and IFN inducer

Shuai H, Chu H, Hou Y, Yang D, Wang Y, Hu B, Huang X, Zhang X, Chai Y, Cai JP, Chan JF, Yuen KY.

Abstract:

Link to Article

An overview of safety assessment of the medicines currently used in the treatment of COVID-19 disease

Javorac D, Grahovac L, Manić L, Stojilković N, Anđelković M, Bulat Z, Đukić-Ćosić D, Curcic M, Djordjevic AB.

Abstract:

Link to Article

Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients

Wang N, Zhan Y, Zhu L, Hou Z, Liu F, Song P, Qiu F, Wang X, Zou X, Wan D, Qian X, Wang S, Guo Y, Yu H, Cui M, Tong G, Xu Y, Zheng Z, Lu Y, Hong P.

Abstract:

Link to Article

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine

Ibrahim H, Perl A, Smith D, Lewis T, Kon Z, Goldenberg R, Yarta K, Staniloae C, Williams M.

Abstract:

Link to Article

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investiga

Abstract:

Link to Article

Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care

Olender SA, Perez KK, Go AS, Balani B, Price-Haywood EG, Shah NS, Wang S, Walunas TL, Swaminathan S, Slim J, Chin B, De Wit S, Ali SM, Soriano Viladomiu A, Robinson P, Gottlieb RL, Tsang TYO, Lee IH, Haubrich RH, Chokkalingam AP, Lin L, Zhong L, Bekele BN, Mera-Giler R, Gallant J, Smith LE, Osinusi AO, Brainard DM, Hu H, Phulpin C, Edgar H, Diaz-Cuervo H, Bernardino JI.

Abstract:

Link to Article

Audio Interview: Dexamethasone and Covid-19

Rubin EJ, Baden LR, Morrissey S.

Abstract:

Link to Article

The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review

Venkatesulu BP, Thoguluva Chandrasekar V, Girdhar P, Pragathee V, Patel HK, Manteuffel J.

Abstract:

Link to Article

Effect of temperature and humidity on the dynamics of daily new cases and deaths due to COVID-19 outbreak in Gulf countries in Middle East Region

Meo SA, Abukhalaf AA, Alomar AA, Alsalame NM, Al-Khlaiwi T, Usmani AM.

Abstract:

Link to Article

The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown

Ghermandi R, Pipola V, Terzi S, Tedesco G, Cavallari C, Bandiera S, Barbanti Bròdano G, Evangelisti G, Girolami M, Gasbarrini A.

Abstract:

Link to Article

Impact of COVID-19 on otolaryngology in Italy: a commentary from the COVID-19 task force of the Young Otolaryngologists of the Italian Society of Otolaryngology

Ralli M, Mannelli G, Bonali M, Capasso P, Guarino P, Iannini V, Mevio N, Russo G, Scarpa A, Spinato G, Topazio D, Molteni G.

Abstract:

Link to Article

Assisted reproduction and Coronavirus in Italy

Pasquale C, Montanino Oliva M, Benedetti M, Berlinghieri V, Bielli W, Buonomo G, Carfagna P, Costantino A, Cristofano D, Iacomino D, Lippa A, Lisi R, Ortensi I, Quinzi A, Giorlandino C, Lisi F.

Abstract:

Link to Article

Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19

Papa A, Covino M, Pizzolante F, Miele L, Lopetuso LR, Bove V, Iorio R, Simeoni B, Vetrone LM, Tricoli L, Mignini I, Schepis T, D'Alessandro A, Coppola G, Nicoletti T, Visconti E, Rapaccini G.

Abstract:

Link to Article

CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients

Zhang N, Zhao YD, Wang XM.

Abstract:

Link to Article

Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2

Gonz√°lez-Pacheco H, Amezcua-Guerra LM, Sandoval J, Arias-Mendoza A.

Abstract:

Link to Article

Understanding and implementing alternative solutions to address the COVID-19 pandemic in the sense of public health emergencies

Bhole RP, Sarode VI, Bonde CG.

Abstract:

Link to Article

A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients

Solis-García Del Pozo J, Galindo MF, Nava E, Jordán J.

Abstract:

Link to Article

Palliative Care During COVID-19: Data and Visits From Loved Ones

Heath L, Yates S, Carey M, Miller M.

Abstract:

Link to Article

Benzothiazoles as potential antiviral agents

Asiri YI, Alsayari A, Muhsinah AB, Mabkhot YN, Hassan MZ.

Abstract:

Link to Article

High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection

Taramasso L, Di Biagio A, Mikulska M, Roberto Giacobbe D, Vena A, Dentone C, De Maria A, Delfino E, Berruti M, Russo C, Orsi A, Bruzzone B, Bassetti M.

Abstract:

Link to Article

Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M.

Abstract:

Link to Article

Traditional Chinese medicine for combating COVID-19

Chen K, Chen H.

Abstract:

Link to Article

Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases

Bazzell B, Wagner D, Durant KM, Callahan B.

Abstract:

Link to Article

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide

Wang Z, Wang Y, Vilekar P, Yang SP, Gupta M, Oh MI, Meek A, Doyle L, Villar L, Brennecke A, Liyanage I, Reed M, Barden C, Weaver DF.

Abstract:

Link to Article

Coronavirus disease 2019 drug discovery through molecular docking

Singh S, Florez H.

Abstract:

Link to Article

Next-generation vaccine platforms for COVID-19

van Riel D, de Wit E.

Abstract:

Link to Article

COVID-19 therapies and vaccine landscape

Abstract:

Link to Article

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

Lv Z, Deng YQ, Ye Q, Cao L, Sun CY, Fan C, Huang W, Sun S, Sun Y, Zhu L, Chen Q, Wang N, Nie J, Cui Z, Zhu D, Shaw N, Li XF, Li Q, Xie L, Wang Y, Rao Z, Qin CF, Wang X.

Abstract:

Link to Article

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection

Murphy M, Estcourt L, Grant-Casey J, Dzik S.

Abstract:

Link to Article

THE RATIONALE FOR A MULTI-STEP THERAPEUTIC APPROACH BASED ON ANTIVIRALS, DRUGS, AND NUTRIENTS WITH IMMUNOMODULATORY ACTIVITY IN PATIENTS WITH CORONAVIRUS-SARS2-INDUCED DISEASE OF DIFFERENT SEVERITY

Fiorino S, Zippi M, Gallo C, Sifo D, Sabbatani S, Manfredi R, Rasciti E, Rasciti L, Giampieri E, Corazza I, Leandri P, de Biase D.

Abstract:

Link to Article

Antimicrobial prescribing practices at a tertiary care center in patients diagnosed with COVID-19 across the continuum of care

Stevens RW, Jensen K, O'Horo JC, Shah A.

Abstract:

Link to Article

Promise and challenges in the development of COVID-19 vaccines

Chen W.

Abstract:

Link to Article

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines

Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K.

Abstract:

Link to Article

Integrative role of traditional and modern technologies to combat COVID-19

Heiat M, Hashemi-Aghdam MR, Heiat F, Rastegar Shariat Panahi M, Aghamollei H, Moosazadeh Moghaddam M, Sathyapalan T, Ranjbar R, Sahebkar A.

Abstract:

Link to Article

Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): A protocol for systematic review and meta analysis

Liu D, You Y, Chen Y, Tang S.

Abstract:

Link to Article

A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia

Dongala T, Ettaboina SK, Katari NK.

Abstract:

Link to Article

Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest

Hartman WR, Hess AS, Connor JP.

Abstract:

Link to Article

Evolution of effective serial interval of SARS-CoV-2 by non-pharmaceutical interventions

Ali ST, Wang L, Lau EHY, Xu XK, Du Z, Wu Y, Leung GM, Cowling BJ.

Abstract:

Link to Article

Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19

Usman M, Farooq M, Hanna K.

Abstract:

Link to Article

Encouraging results from phase 1/2 COVID-19 vaccine trials

Bar-Zeev N, Moss WJ.

Abstract:

Link to Article

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W.

Abstract:

Link to Article

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group.

Abstract:

Link to Article

Clozapine in the Time of COVID-19

Boland X, Dratcu L.

Abstract:

Link to Article

Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy

Helleberg M, Niemann CU, Moestrup K, Kirk O, Lebech AM, Lane C, Lundgren J.

Abstract:

Link to Article

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

O'Donovan SM, Eby H, Henkel ND, Creeden J, Imami A, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE.

Abstract:

Link to Article

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

Satlin MJ, Goyal P, Magleby R, Maldarelli GA, Pham K, Kondo M, Schenck EJ, Rennert H, Westblade LF, Choi JJ, Safford MM, Gulick RM.

Abstract:

Link to Article

YouTube coverage of COVID-19 vaccine development: implications for awareness and uptake

Basch CH, Hillyer GC, Zagnit EA, Basch CE.

Abstract:

Link to Article

Designing Pull Funding For A COVID-19 Vaccine

Snyder CM, Hoyt K, Gouglas D, Johnston T, Robinson J.

Abstract:

Link to Article

A Dangerous "Cocktail": The COVID-19 Pandemic and the Youth Opioid Crisis in North America: A Response to Vigo et al. (2020)

Jayasinha R, Nairn S, Conrod P.

Abstract:

Link to Article

Treating COVID-19: Review of drug hypersensitivity reactions

Dordal Culla MT, Herrera-Lasso Regás V, Martí-Garrido J, Rodríguez Cumplido D, Vázquez-Revuelta P, Lleonart Bellfill R.

Abstract:

Link to Article

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020

Harvala H, Mehew J, Robb ML, Ijaz S, Dicks S, Patel M, Watkins N, Simmonds P, Brooks T, Johnson R, Gopal R, Roberts DJ, Zambon M; NHS Blood and Transplant Convalescent Plasma Testing Group.

Abstract:

Link to Article

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

Loganathan S, Athalye SN, Joshi SR.

Abstract:

Link to Article

Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety

Akhtar S, Benter IF, Danjuma MI, Doi SAR, Hasan SS, Habib AM.

Abstract:

Link to Article

Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia

Stremmel C, Kellnar A, Massberg S, Kääb S.

Abstract:

Link to Article

[Characteristics of SARS-CoV-2 and potential pharmacological treatment]

Pawlik L, Śpiołek E, Fichna J, Tarasiuk A.

Abstract:

Link to Article

Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties

Rosenbloom DS, Zhao P, Sinha V.

Abstract:

Link to Article

Non-steroidal anti-inflammatory drugs, prostaglandins and COVID-19

Robb CT, Goepp M, Rossi AG, Yao C.

Abstract:

Link to Article

Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19

Rogosnitzky M, Okediji P, Koman I.

Abstract:

Link to Article

Corticosteroid Injections and COVID-19 Infection Risk

Miller DC, Patel J, Gill J, Mattie R, Saffarian M, Schneider BJ, Popescu A, Babaria V, McCormick ZL.

Abstract:

Link to Article

Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?

Shover CL, Humphreys K.

Abstract:

Link to Article

NICE cautions against using graded exercise therapy for patients recovering from covid-19

Abstract:

Link to Article

Impact of COVID-19 on Pneumonia-Focused Antibiotic Use at an Academic Medical Center

Nestler M, Godbout E, Lee K, Kim J, Noda AJ, Taylor P, Pryor R, Markley JD, Doll M, Bearman G, Stevens MP.

Abstract:

Link to Article

Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives

Pawełczyk A, Zaprutko L.

Abstract:

Link to Article

Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis

Kang K, Kim HH, Choi Y.

Abstract:

Link to Article

Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development

Corral-Lugo A, López-Siles M, López D, McConnell MJ, Martin-Galiano AJ.

Abstract:

Link to Article

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R.

Abstract:

Link to Article

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Hoffmann M, Mösbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Krüger N, Gassen NC, Müller MA, Drosten C, Pöhlmann S.

Abstract:

Link to Article

Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic

Cochran G, Bruneau J, Cox N, Gordon AJ.

Abstract:

Link to Article

Corticosteroids-induced osteonecrosis in COVID-19: a call for caution

Zhang B, Zhang S.

Abstract:

Link to Article

Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis

Jin L, Xu Y, Yuan H.

Abstract:

Link to Article

Use of remdesivir for patients with Covid-19: a review article

Azevedo TCP, Azevedo PCP, Silveira Filho RN, Carvalho ARVS, Cezarotti Filho ML, Barbosa FT, Sousa-Rodrigues CF, Matos-Rocha TJ, Ramos FWDS.

Abstract:

Link to Article

Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports

Wei B, Hang X, Xie Y, Zhang Y, Wang J, Cao X, Wu JJ, Wang J.

Abstract:

Link to Article

Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19

Sehailia M, Chemat S.

Abstract:

Link to Article

Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state

McCarthy C, Savinelli S, Feeney ER, Butler MW, O'Broin C, Ryan S, O'Neill L, Murphy DJ, Gallagher CG, McKone EF, Waqas S, Cotter A, Doran P, Keane MP, Mallon PW.

Abstract:

Link to Article

The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review

Paganini M, Bosco G, Perozzo FAG, Kohlscheen E, Sonda R, Bassetto F, Garetto G, Camporesi EM, Thom SR.

Abstract:

Link to Article

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines

Sultana J, Cutroneo PM, Crisafulli S, Puglisi G, Caramori G, Trifirò G.

Abstract:

Link to Article

Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy

Berishvili E, Kaiser L, Cohen M, Berney T, Scholz H, Floisand Y, Mattsson J.

Abstract:

Link to Article

A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial

Hu K, Wang M, Zhao Y, Zhang Y, Wang T, Zheng Z, Li X, Zeng S, Zhao D, Li H, Xu K, Lan K.

Abstract:

Link to Article

Pharmaco-Immunomodulatory Therapy in COVID-19

Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN.

Abstract:

Link to Article

Cellular Therapy: Shafts of Light Emerging for COVID-19

Jeyaraman M, Ranjan R, Kumar R, Arora A, Chaudhary D, Ajay SS, Jain R.

Abstract:

Link to Article

Hydroxychloroquine in Dermatology and Beyond: Recent Update

Sardana K, Sinha S, Sachdeva S.

Abstract:

Link to Article

Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective

Bayoumy AB, de Boer NKH, Ansari AR, Crouwel F, Mulder CJJ.

Abstract:

Link to Article

Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists

Mehta B, Moezinia CJ, Jannat-Khah D, Gibofsky A, Tornberg H, Pearce-Fisher D, Goodman SM, Salmon JE, Ibrahim S.

Abstract:

Link to Article

Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions

Ali ST, Wang L, Lau EHY, Xu XK, Du Z, Wu Y, Leung GM, Cowling BJ.

Abstract:

Link to Article

NICE advises against using graded exercise therapy for patients recovering from covid-19

Torjesen I.

Abstract:

Link to Article

Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases

Puri N, Coomes EA, Haghbayan H, Gunaratne K.

Abstract:

Link to Article

COVID-19 - Important considerations for developing and using a vaccine

Rahman IU, Ali N, Ijaz F, Afzal A, Abd Allah EF.

Abstract:

Link to Article

Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection

Infante M, Ricordi C, Alejandro R, Caprio M, Fabbri A.

Abstract:

Link to Article

Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study

Tomasiewicz K, Piekarska A, Stempkowska-Rejek J, Serafińska S, Gawkowska A, Parczewski M, Niścigorska-Olsen J, Łapiński TW, Zarębska-Michaluk D, Kowalska JD, Horban A, Flisiak R.

Abstract:

Link to Article

A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib

Peng L, Xiao K, Ottaviani S, Stebbing J, Wang YJ.

Abstract:

Link to Article

Model-Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID-19

Dodds MG, Krishna R, Goncalves A, Rayner CR.

Abstract:

Link to Article

Fibrinolysis and COVID-19: a tale of two sites?

Keragala CB, Medcalf RL, Myles PS.

Abstract:

Link to Article

Stem cell therapies for COVID-19: Strategy and application

Darabi R, Li Y.

Abstract:

Link to Article

High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Liaquat H, Shupp B, Kapoor S, Matin A.

Abstract:

Link to Article

Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?

Majbour N, El-Agnaf O.

Abstract:

Link to Article

Repurposing Existing Drugs for the Treatment of COVID-19

Farne H, Kumar K, Ritchie AI, Finney LJ, Johnston SL, Singanayagam A.

Abstract:

Link to Article

ABNORMAL LABORATORY FINDINGS AND PLASMA CONCENTRATION MONITORING OF LOPINAVIR AND RITONAVIR IN COVID-19

Batteux B, Bodeau S, Gras-Champel V, Liabeuf S, Lanoix JP, Schmit JL, Andréjak C, Zerbib Y, Haye G, Masmoudi K, Lemaire-Hurtel AS, Bennis Y.

Abstract:

Link to Article

Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status

Banday AH, Shameem SA, Ajaz SJ.

Abstract:

Link to Article

Drug interactions with potential antivirals used for COVID-19 in older persons

Ho V, Tee C, See KC.

Abstract:

Link to Article

SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen

Wang Y, Wang L, Cao H, Liu C.

Abstract:

Link to Article

Lung Ultrasound for Treatment of Patients With COVID-19: Please Report Your Settings and Mechanical Index

Rosado-Mendez IM, Smargiassi A, Inchingolo R, Soldati G, Muller M, Demi L.

Abstract:

Link to Article

Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia

Gokhale Y, Mehta R, Karnik N, Kulkarni U, Gokhale S.

Abstract:

Link to Article

Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the Evidence

Chastain DB, Stitt TM, Ly PT, Henao-Martínez AF, Franco-Paredes C, Osae SP.

Abstract:

Link to Article

Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective

Panyod S, Ho CT, Sheen LY.

Abstract:

Link to Article

A consensus guideline of herbal medicine for coronavirus disease 2019

Lee BJ, Lee JA, Kim KI, Choi JY, Jung HJ.

Abstract:

Link to Article

Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines

Ang L, Lee HW, Kim A, Lee MS.

Abstract:

Link to Article

Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections

Hunter J, Arentz S, Goldenberg J, Yang G, Beardsley J, Mertz D, Leeder S.

Abstract:

Link to Article

Covid-19: UK agrees "early access" deal with companies to get 90 million vaccine doses

Mahase E.

Abstract:

Link to Article

Dexamethasone for COVID-19: preliminary findings

Abstract:

Link to Article

Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial

Daval M, Corré A, Palpacuer C, Housset J, Poillon G, Eliezer M, Verillaud B, Slama D, Ayache D, Herman P, Jourdaine C, Hervé C, El Bakkouri W, Salmon D, Hautefort C.

Abstract:

Link to Article

Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin

Kelly M, O'Connor R, Townsend L, Coghlan M, Relihan E, Moriarty M, Carr B, Melanophy G, Doyle C, Bannan C, O'Riordan R, Merry C, Clarke S, Bergin C.

Abstract:

Link to Article

Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection

Nicol MR, Joshi A, Rizk ML, Sabato PE, Savic RM, Wesche D, Zheng JH, Cook J.

Abstract:

Link to Article

Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns

Jankowska EA, Sierpiński R, Tkaczyszyn M, Drozd M, Szachniewicz J, Duda-Sikuła M, Knysz B, Simon K, Szenborn L, Ponikowski P.

Abstract:

Link to Article

QT Interval Evaluation Associated With Use of Hydroxychloroquine with Combined Use of Azithromycin Among Hospitalized Children Positive for COVID-19

Tuncer T, Karaci M, Boga A, Durmaz H, Guven S.

Abstract:

Link to Article

Insights in chloroquine action: perspectives and implications in Malaria and COVID-19

Pillat MM, Krüger A, Guimarães LMF, Lameu C, de Souza EE, Wrenger C, Ulrich H.

Abstract:

Link to Article

Senolytic Drugs: From Discovery to Translation

Kirkland JL, Tchkonia T.

Abstract:

Link to Article

Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients

Korman TM.

Abstract:

Link to Article

RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED-UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS

Peiffer-Smadja N, Costagliola D.

Abstract:

Link to Article

Commentary: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis"

Fleury V.

Abstract:

Link to Article

Response to: "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients" and "Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis"

Risch HA.

Abstract:

Link to Article

Response to: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis"

Risch HA.

Abstract:

Link to Article

Antiviral anticoagulation

Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M.

Abstract:

Link to Article

Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation

Antony SJ, Singh J, de Jesus M, Lance J.

Abstract:

Link to Article

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?

Ch'ng ES, Tang TH.

Abstract:

Link to Article

Planning for COVID-19 vaccines safety surveillance

Kochhar S, Salmon DA.

Abstract:

Link to Article

[A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation]

Xie W, Zhong Z, Li G, Hou G, Huang K, Yu Z.

Abstract:

Link to Article

[Meta-analysis of single-group rate of the distribution of traditional Chinese medicine syndromes in 2 139 patients with coronavirus disease 2019]

Li X, Liu W, He W, Xie Y, Li J.

Abstract:

Link to Article

[Exploration on the therapeutic mechanisms and safety of blood components of convalescents without erythrocytes on severe acute respiratory syndrome and coronavirus disease 2019]

Feng W, Du B, Feng B.

Abstract:

Link to Article

[Application of convalescent plasma for the treatment of adult patients with coronavirus disease 2019]

Li S, Zhao H, Sun Y, Wang P, Li H, Duan M.

Abstract:

Link to Article

Withaferin A: a potential therapeutic agent against COVID-19 infection

Straughn AR, Kakar SS.

Abstract:

Link to Article

Worrying situation regarding the use of dexamethasone for COVID-19

Lim MA, Pranata R.

Abstract:

Link to Article

Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)

Subir R, Jagat J M, Kalyan K G.

Abstract:

Link to Article

Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19

Kipshidze N, Chekanov VS, Kipshidze N, Reddy VY, Dangas G.

Abstract:

Link to Article

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19

Cortegiani A, Ippolito M, Ingoglia G, Iozzo P, Giarratano A, Einav S.

Abstract:

Link to Article

Are statins safe in patients with COVID-19?

Karalis DG.

Abstract:

Link to Article

Advances in the possible treatment of COVID-19: A review

Chibber P, Haq SA, Ahmed I, Andrabi NI, Singh G.

Abstract:

Link to Article

Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Wright Z, Bersabe A, Eden R, Cap A.

Abstract:

Link to Article

The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data

Tanriverdİ E, ÇÖrtÜk M, Yildirim BZ, UĞur Chousein EG, Turan D, Çinarka H, ÖzgÜl MA, Çetİnkaya E.

Abstract:

Link to Article

Safety perspectives on presently considered drugs for the treatment of COVID-19

Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE.

Abstract:

Link to Article

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy

Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, Gerli R.

Abstract:

Link to Article

How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed Clinical Trials and Patient Care During the COVID-19 Pandemic

Schilling S, Mohanarajah S, Mengstu A, Khan A, Brown WA.

Abstract:

Link to Article

Therapeutic Limitation in Elderly Patients: Reflections Regarding COVID19

Segrelles-Calvo G, de Granda-Orive JI, López-Padilla D, Zamora García E.

Abstract:

Link to Article

Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome

Faqihi F, Alharthy A, Karakitsos D.

Abstract:

Link to Article

Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?

Krawczyk N, Fingerhood MI, Agus D.

Abstract:

Link to Article

Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report

Girija PLT, Sivan N.

Abstract:

Link to Article

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series

Stallmach A, Kortgen A, Gonnert F, Coldewey SM, Reuken P, Bauer M.

Abstract:

Link to Article

A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report

Crowley D, Delargy I.

Abstract:

Link to Article

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes

Zettl F, Meister TL, Vollmer T, Fischer B, Steinmann J, Krawczyk A, V'kovski P, Todt D, Steinmann E, Pfaender S, Zimmer G.

Abstract:

Link to Article

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA.

Abstract:

Link to Article

Supplementation with vitamin D in the COVID-19 pandemic?

Hadizadeh F.

Abstract:

Link to Article

Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?

Taştemur Ş, Ataseven H.

Abstract:

Link to Article

Learning from history: do not flatten the curve of antiviral research!

Bobrowski T, Melo-Filho CC, Korn D, Alves VM, Popov KI, Auerbach S, Schmitt C, Moorman NJ, Muratov EN, Tropsha A.

Abstract:

Link to Article

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis

Hazra S, Chaudhuri AG, Tiwary BK, Chakrabarti N.

Abstract:

Link to Article

Management of Phototherapy Units During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Photobiology Group

Aguilera P, Gilaberte Y, Pérez-Ferriols A, de Argila D, Aguilera J, de Galvez MV, Granados MT, Gardeazabal J, Carrascosa JM; del Grupo Español de Fotobiología.

Abstract:

Link to Article

Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa

Brotherton H, Usuf E, Nadjm B, Forrest K, Bojang K, Samateh AL, Bittaye M, Roberts CA, d'Alessandro U, Roca A.

Abstract:

Link to Article

Lopinavir-ritonavir for COVID-19: A living systematic review

Verdugo-Paiva F, Izcovich A, Ragusa M, Rada G.

Abstract:

Link to Article

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

Cohen SA, Kellogg C, Equils O.

Abstract:

Link to Article

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ.

Abstract:

Link to Article

Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation

Jiang S, Petriceks AH, Burke H, Stern TA.

Abstract:

Link to Article

Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19

Koenig LM, Boehmer DFR, Metzger P, Schnurr M, Endres S, Rothenfusser S.

Abstract:

Link to Article

A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report

Peng H, Gong T, Huang X, Sun X, Luo H, Wang W, Luo J, Luo B, Chen Y, Wang X, Long H, Mei H, Li C, Dai Y, Li H.

Abstract:

Link to Article

Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study

Celı K I, Onay-Besı Kcı A, Ayhan-Kilcigı L G.

Abstract:

Link to Article

Efficacy of Povidone-Iodine to Reduce Viral Load

Cimolai N.

Abstract:

Link to Article

The cardiovascular effects of treatment with hydroxychloroquine and azithromycin

Simmering JE, Polgreen LA, Polgreen PM, Teske RE, Comellas AP, Carter BL.

Abstract:

Link to Article

Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial

Wang JB, Wang ZX, Jing J, Zhao P, Dong JH, Zhou YF, Yang G, Niu M, Zhao X, Jiang TJ, Bi JF, Xu Z, Zhang P, Wu D, Bai ZF, Guo YM, Yu SM, Sun YQ, Zhang ZT, Zhan XY, Li PY, Ding JB, Zhao PF, Song XA, Tang JY, He DC, Chen Z, Qin EQ, Wang RL, Xiao XH.

Abstract:

Link to Article

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection

Moschini L, Loffi M, Regazzoni V, Di Tano G, Gherbesi E, Danzi GB.

Abstract:

Link to Article

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic

Coombes I, Markwell A, Kubler P, Redmond AM, McGurk G, Roberts JA.

Abstract:

Link to Article

Role for antimalarials in the management of COVID-19

Schrezenmeier EV, Burmester GR, Eckardt KU, Dörner T.

Abstract:

Link to Article

Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: Three case reports

Su Y, Han Y, Liu J, Qiu Y, Tan Q, Zhou Z, Yu YZ, Chen J, Giger ML, Lure FYM, Luo Z.

Abstract:

Link to Article

COVID-19, hydroxychloroquine and the eighth alternative

Chattopadhyay A, Chaudhuri K.

Abstract:

Link to Article

Contribution of traditional Chinese medicine to the treatment of COVID-19

Wang WY, Xie Y, Zhou H, Liu L.

Abstract:

Link to Article

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

Machiels JD, Bleeker-Rovers CP, Ter Heine R, Rahamat-Langendoen J, de Mast Q, Ten Oever J, Bousema T, van Crevel R, Wertheim HF.

Abstract:

Link to Article

Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949

Rosendaal FR.

Abstract:

Link to Article

Plasma Therapies and Parabiosis in the COVID-19 Era

Calvani R, Picca A, Landi F, Marzetti E.

Abstract:

Link to Article

[Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)]

Kolditz M, Dellweg D, Geerdes-Fenge H, Lepper PM, Schaberg T, Ewig S, Pfeifer M, Bauer T.

Abstract:

Link to Article

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Mitjà O, Corbacho-Monné M, Ubals M, Tebe C, Peñafiel J, Tobias A, Ballana E, Alemany A, Riera-Martí N, Pérez CA, Suñer C, Laporte P, Admella P, Mitjà J, Clua M, Bertran L, Sarquella M, Gavilán S, Ara J, Argimon JM, Casabona J, Cuatrecasas G, Cañadas P, Elizalde-Torrent A, Fabregat R, Farré M, Forcada A, Flores-Mateo G, Muntada E, Nadal N, Narejos S, Gil-Ortega AN, Prat N, Puig J, Quiñones C, Reyes-Ureña J, Ramírez-Viaplana F, Ruiz L, Riveira-Muñoz E, Sierra A, Velasco C, Vivanco-Hi

Abstract:

Link to Article

Re: Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?

Bevelacqua JJ, Mortazavi S, Mortazavi S.

Abstract:

Link to Article

Chinese Herbal Medicines During the Covid-19 Pandemic: A Role for Observational Studies

Citkovitz C, Schnyer RN.

Abstract:

Link to Article

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR.

Abstract:

Link to Article

The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale

Schluger NW.

Abstract:

Link to Article

Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study

Fernández-Ruiz M, López-Medrano F, Asín MAP, de la Calle GM, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, Juan RS, Trujillo H, Lumbreras C, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group.

Abstract:

Link to Article

Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs

Duran-Frigola M, Bertoni M, Blanco R, Martínez V, Pauls E, Alcalde V, Turon G, Villegas N, Fernández-Torras A, Pons C, Mateo L, Guitart-Pla O, Badia-I-Mompel P, Gimeno A, Soler N, Brun-Heath I, Zaragoza H, Aloy P.

Abstract:

Link to Article

COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases

Baker D, Roberts CA, Pryce G, Kang AS, Marta M, Reyes S, Schmierer K, Giovannoni G, Amor S.

Abstract:

Link to Article

Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics

Kandimalla R, John A, Abburi C, Vallamkondu J, Reddy PH.

Abstract:

Link to Article

Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors

Sing CW, Tan KCB, Wong ICK, Cheung BMY, Cheung CL.

Abstract:

Link to Article

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19

Chen J, Xia L, Liu L, Xu Q, Ling Y, Huang D, Huang W, Song S, Xu S, Shen Y, Lu H.

Abstract:

Link to Article

Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis

Sodani P, Mucci L, Girolimetti R, Tedesco S, Monaco F, Campanozzi D, Brunori M, Maltoni S, Bedetta S, Di Carlo AM, Candoli P, Mancini M, Rebonato A, D'Adamo F, Capalbo M, Frausini G.

Abstract:

Link to Article

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids

Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K.

Abstract:

Link to Article

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Wang Y, Zhang Y, Yu Q, Zhu K.

Abstract:

Link to Article

Pharmacotherapics Advice in Guidelines for COVID-19

Chen ZR, Zhou Y, Liu J, Peng HW, Zhou J, Zhong HL, Liu LL, Lai MF, Wei XH, Wen JH.

Abstract:

Link to Article

Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review

Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI.

Abstract:

Link to Article

How computational immunology changed the face of COVID-19 vaccine development

Arnold C.

Abstract:

Link to Article

COVID-19 vaccine development and a potential nanomaterial path forward

Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA, Wirth DM, Chen A, Sack M, Pokorski JK, Steinmetz NF.

Abstract:

Link to Article

Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research

Wang J, Qi F.

Abstract:

Link to Article

Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies

Marouf BH, Dizaye K.

Abstract:

Link to Article

Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "The Diagnosis and Treatment Program for Coronavirus Disease-2019" from Chinese Authority

Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH, Li H.

Abstract:

Link to Article

COVID-19 Therapeutics: Making Sense of It All

Bakare LS, Allen JM.

Abstract:

Link to Article

A Molecular Docking Study Repurposes FDA Approved Iron Oxide Nanoparticles to Treat and Control COVID-19 Infection

Abo-Zeid Y, Ismail NS, McLean GR, Hamdy NM.

Abstract:

Link to Article

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Pruijssers AJ, George AS, Schäfer A, Leist SR, Gralinksi LE, Dinnon KH 3rd, Yount BL, Agostini ML, Stevens LJ, Chappell JD, Lu X, Hughes TM, Gully K, Martinez DR, Brown AJ, Graham RL, Perry JK, Du Pont V, Pitts J, Ma B, Babusis D, Murakami E, Feng JY, Bilello JP, Porter DP, Cihlar T, Baric RS, Denison MR, Sheahan TP.

Abstract:

Link to Article

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply

Okafor EC, Pastick KA, Rajasingham R.

Abstract:

Link to Article

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Tekwani BL.

Abstract:

Link to Article

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Khan MS, Butler J.

Abstract:

Link to Article

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Avidan MS, Dehbi HM, Delany-Moretlwe S.

Abstract:

Link to Article

Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19

Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM.

Abstract:

Link to Article

Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection

Chandrasekar VT, Venkatesalu B, Patel HK, Spadaccini M, Manteuffel J, Ramesh M.

Abstract:

Link to Article

On Treatments and Tests Deferred: Preparing for Collateral Damage from COVID-19

Jain S, Santhosh L.

Abstract:

Link to Article

COVID 19 and manual therapy: international lessons and perspectives on current and future clinical practice and education

MacDonald CW, Lonnemann E, Petersen SM, Rivett DA, Osmotherly PG, Brismée JM.

Abstract:

Link to Article

Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID-19)

Sun X, Li S, Li K, Hu X.

Abstract:

Link to Article

Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options

Huang B, Ling R, Cheng Y, Wen J, Dai Y, Huang W, Zhang S, Lu X, Luo Y, Jiang YZ.

Abstract:

Link to Article

Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment

Di Tano G, Moschini L, Loffi M, Testa S, Danzi GB.

Abstract:

Link to Article

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

Yan VC, Muller FL.

Abstract:

Link to Article

Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment

Kumar K, Lupoli TJ.

Abstract:

Link to Article

Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol

Dambha-Miller H, Albasri A, Hodgson S, Wilcox C, Islam N, Khan S, Little P, Griffin S.

Abstract:

Link to Article

Covid-19: Experts criticise claim that remdesivir cuts death rates

Day M.

Abstract:

Link to Article

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Aricò E, Bracci L, Castiello L, Gessani S, Belardelli F.

Abstract:

Link to Article

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review

Grange L, Guilpain P, Truchetet ME, Cracowski JL; Société française de pharmacologie et de thérapeutique (SFPT).

Abstract:

Link to Article

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Denholm JT, Davis J, Paterson D, Roberts J, Morpeth S, Snelling T, Zentner D, Rees M, O'Sullivan M, Price D, Bowen A, Tong SYC; ASCOT Investigator Group.

Abstract:

Link to Article

Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada

Wright JK, Tan DHS, Walmsley SL, Hulme J, O'Connor E, Snider C, Cheng I, Chan AK, Borgundvaag B, McLeod S, Gollob MH, Clarke RJ, Dresser L, Haji F, Mazzulli T, Mubareka S, Jüni P, Lee D, Tomlinson G, Kain KC, Landes M.

Abstract:

Link to Article

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

McEniery CM, Fisk M, Miles K, Kaloyirou F, Hubsch A, Smith J, Wilkinson IB, Cheriyan J.

Abstract:

Link to Article

Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study

Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, Chung CW, Trelles-Garcia VP, Friedman HJ.

Abstract:

Link to Article

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Serdar D, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C.

Abstract:

Link to Article

Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients

Cala-García JD, Sierra-Bretón JD, Cavelier-Baiz JE, Faccini-Martínez ÁA, Pérez-Díaz CE.

Abstract:

Link to Article

Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis

Klinger D, Blass I, Rappoport N, Linial M.

Abstract:

Link to Article

Tuina (massage) therapy for diarrhea in COVID-19: A protocol for systematic review and meta-analysis

Zhou KL, Dong S, Fu GB, Cui SS, Guo S.

Abstract:

Link to Article

The efficacy of acupuncture for improving the side effects of COVID-19 western medicine treatments: A protocol for a systematic review and meta-analysis

Huang KY, Chang CH, Hsu CH.

Abstract:

Link to Article

Efficacy of acupuncture and moxibustion in adjuvant treatment of patients with novel coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis

Zhang Q, Xu X, Sun S, Cao F, Li J, Qi X, Ji G, Wang Y, Song B.

Abstract:

Link to Article

The Covid-19 Vaccine-Development Multiverse

Heaton PM.

Abstract:

Link to Article

COVID-19 & antiepileptic drugs: Should we pay attention?

Fırat O, Yalçın N, Demirkan K.

Abstract:

Link to Article

Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate

Acharya R.

Abstract:

Link to Article

Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation

Foppiani A, Bertoli S, Battezzati A, Zuccotti G.

Abstract:

Link to Article

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'

McIlroy JR, Mullish BH, Goldenberg SD, Ianiro G, Marchesi JR.

Abstract:

Link to Article

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein

Sheikhi A, Hojjat-Farsangi M.

Abstract:

Link to Article

The Use of IV vitamin C for patients with COVID-19: a single center observational study

Hiedra R, Lo KB, Elbashabsheh M, Gul F, Wright RM, Albano J, Azmaiprashvili Z, Patarroyo Aponte G.

Abstract:

Link to Article

N-acetylcysteine as a potential treatment for novel coronavirus disease 2019

Jorge-Aarón RM, Rosa-Ester MP.

Abstract:

Link to Article

Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome

Sadia A, Basra MAR.

Abstract:

Link to Article

Tocilizumab, Adipokines and Severe Complications of COVID-19

Fioravanti A, Porcelli B, Terzuoli L, Bacarelli MR, Tenti S, Cheleschi S.

Abstract:

Link to Article

Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19

Liu B, Qi Z.

Abstract:

Link to Article

Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?

Singh V.

Abstract:

Link to Article

An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2

Schiffer JT, Johnston C, Wald A, Corey L.

Abstract:

Link to Article

Drug targets for COVID-19 therapeutics: Ongoing global efforts

Saxena A.

Abstract:

Link to Article

Informing critical care drug requirements in response to the COVID-19 pandemic

Hogg A, Huey R, Scott MG, Ferguson A.

Abstract:

Link to Article

Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial

Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS.

Abstract:

Link to Article

Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver-stage of Plasmodium cynomolgi infection in Rhesus Macaques

Vanachayangkul P, Im-Erbsin R, Tungtaeng A, Kodchakorn C, Roth A, Adams J, Chaisatit C, Saingam P, Sciotti RJ, Reichard GA, Nolan CK, Pybus BS, Black CC, Lugo-Roman LA, Wegner MD, Smith PL, Wojnarski M, Vesely BA, Kobylinski KC.

Abstract:

Link to Article

Response to: Amantadine Treatment for People with COVID-19

Wiwanitkit V.

Abstract:

Link to Article

A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a stu

Smith K, Pace A, Ortiz S, Kazani S, Rottinghaus S.

Abstract:

Link to Article

Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review

Higgins TS, Wu AW, Illing EA, Sokoloski KJ, Weaver BA, Anthony BP, Hughes N, Ting JY.

Abstract:

Link to Article

Pros and cons of corticosteroid therapy for COVID-19 patients

Mattos-Silva P, Felix NS, Silva PL, Robba C, Battaglini D, Pelosi P, Rocco PRM, Cruz FF.

Abstract:

Link to Article

[Cardiac adverse effects of hydroxychloroquine and the need for tests]

Zaidel EJ, Wyss Quintana FS, Sosa Liprandi Á, Mendoza I, Márquez MF, Nuñez E, Barbosa M, Baranchuk A.

Abstract:

Link to Article

[Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic]

Bozzo R, Ibelli F, Scublinsky D.

Abstract:

Link to Article

[Use of convalescent plasma for COVID-19 treatment. History and evidence]

McAllister F, Mantegazza A, Garzón F, Rotbaum V, Remondino G, Vazquez Larsson M, Geffner J, Rabinovich GA, Bover L.

Abstract:

Link to Article

[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]

Vazquez FJ, Korin J, Baldessari EM, Capparelli FJ, Gutierrez P, Pale C, Bocanegra F, Grand B, Penchasky D, Gonzalez Alcántara MM, Prémoli MS, Tabares A, Wainsztein N, Odetto D, Vaccaro C, Martínez Aquino E, Cumpian O, Falabella V, Antuel García S, Saadi J, Siccardi M, Gándara E.

Abstract:

Link to Article

Development of a hyperimmune equine serum therapy for COVID-19 in Argentina

Zylberman V, Sanguineti S, Pontoriero AV, Higa SV, Cerutti ML, Morrone Seijo SM, Pardo R, Muñoz L, Acuña Intrieri ME, Alzogaray VA, Avaro MM, Benedetti E, Berguer PM, Bocanera L, Bukata L, Bustelo MS, Campos AM, Colonna M, Correa E, Cragnaz L, Dattero ME, Dellafiore M, Foscaldi S, González JV, Guerra LL, Klinke S, Labanda MS, Lauché C, López JC, Martínez AM, Otero LH, Peyric EH, Ponziani PF, Ramondino R, Rinaldi J, Rodríguez S, Russo JE, Russo ML, Saavedra SL, Seigelchifer M, Sosa S, Vila

Abstract:

Link to Article

Montelukast drug activity and potential against SARS-CoV-2

Copertino DC Jr, Duarte RRR, Powell TR, Rougvie MM, Nixon DF.

Abstract:

Link to Article

Osteopathic Response to the COVID-19 Pandemic

Martinez E, Redding D.

Abstract:

Link to Article

Benefit v. risk when using chloroquine in patients with severe COVID-19 disease

Decloedt EH, Reuter H, Allwood B, Parker A, Koegelenberg CFN, Blockman M, Taljaard J.

Abstract:

Link to Article

Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)

de Lima Menezes G, da Silva RA.

Abstract:

Link to Article

New antivirals and antibacterials based on silver nanoparticles

Pagliaro M, Albo Y, Ciriminna R.

Abstract:

Link to Article

Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin

Parlakpinar H, Polat S, Acet HA.

Abstract:

Link to Article

TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2

Ji X, Tan W, Zhang C, Zhai Y, Hsueh Y, Zhang Z, Zhang C, Lu Y, Duan B, Tan G, Na R, Deng G, Niu G.

Abstract:

Link to Article

Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation?

Hetland G, Johnson E, Bernardshaw SV, Grinde B.

Abstract:

Link to Article

Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes

Schimmel J, Manini AF.

Abstract:

Link to Article

Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19

Bertoldi G, Gianesello L, Calò LA.

Abstract:

Link to Article

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials

Baker EH, Patel K, Ball J, Edwards S, Harrison TS, Kaul A, Koh M, Krishna S, Leaver S, Kumar V, Forton DM.

Abstract:

Link to Article

Clinical trials in the pandemic age: What is fit for purpose?

Hartman D, Heaton P, Cammack N, Hudson I, Dolley S, Netsi E, Norman T, Mundel T.

Abstract:

Link to Article

Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases

Sheianov MV, Udalov YD, Ochkin SS, Bashkov AN, Samoilov AS.

Abstract:

Link to Article

Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?

Arboleda JF, Urcuqui-Inchima S.

Abstract:

Link to Article

Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19

Brown R, Hussein H.

Abstract:

Link to Article

Biologic Therapy in COVID-19

González-Gay MA, Castañeda S, Ancochea J.

Abstract:

Link to Article

Behavioral interventions in acute COVID-19 recovery: A new opportunity for integrated care

Jaywant A, Vanderlind WM, Boas SJ, Dickerman AL.

Abstract:

Link to Article

COVID-19 Pandemic and Africa: From the Situation in Zimbabwe to a Case for Precision Herbal Medicine

Dandara C, Dzobo K, Chirikure S.

Abstract:

Link to Article

First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test

Jimenez AC, Navarrate Navarrete N, Gratacós Gómez AR, Florido López F, Garcia Rodriguez R, Elisa GT.

Abstract:

Link to Article

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

C Hsia B, Greige N, A Quiroz J, S Khokhar A, Daily J, Di Biase L, J Ferrick K, D Fisher J, Krumerman A.

Abstract:

Link to Article

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

Horie S, McNicholas B, Rezoagli E, Pham T, Curley G, McAuley D, O'Kane C, Nichol A, Dos Santos C, Rocco PRM, Bellani G, Laffey JG.

Abstract:

Link to Article

Analysis on the Current Quality Standards of Chinese Materia Medica Used in COVID-19 Prevention and Treatment

Shi YH, Huang YF, Wang-Ying W, Yang L, Zhou H, Sang Z.

Abstract:

Link to Article

Reply to letters vide manuscript ID IPEJ-D-20-00072, and IPEJ-D-20-00073 regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm SocietyÀÆ

Kapoor A, Pandurangi U, Arora V, Gupta A, Jaswal A, Nabar A, Naik A, Naik N, Namboodiri Kk N, Vora A, Yadav R, Saxena A.

Abstract:

Link to Article

The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions

Behl T, Kaur I, Bungau S, Kumar A, Uddin MS, Kumar C, Pal G, Sahil, Shrivastava K, Zengin G, Arora S.

Abstract:

Link to Article

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19

Rogero MM, Leão MC, Santana TM, Pimentel MVMB, Carlini GCG, da Silveira TFF, Gonçalves RC, Castro IA.

Abstract:

Link to Article

Does androgen deprivation therapy protect against severe complications from COVID-19?

Patel VG, Zhong X, Liaw B, Tremblay D, Tsao CK, Galsky MD, Oh WK.

Abstract:

Link to Article

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19

Funck-Brentano C, Nguyen LS, Salem JE.

Abstract:

Link to Article

Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia

Guo Z, Chen Y, Luo X, He X, Zhang Y, Wang J.

Abstract:

Link to Article

Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection

Orf K, Rogosic S, Dexter D, Ancliff P, Badle S, Brierley J, Cheng D, Dalton C, Dixon G, Du Pré P, Grandjean L, Ghorashian S, Mittal P, O'Connor D, Pavasovic V, Rao A, Samarasinghe S, Vora A, Bamford A, Bartram J.

Abstract:

Link to Article

Rapid recovery of a SARS-CoV-2 infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

Mira E, Yarce OA, Ortega C, Fernández S, Pascual NM, Gómez C, Alvarez MA, Molina IJ, Lama R, Santamaria M.

Abstract:

Link to Article

Retrospective Analysis of Dermatological Adverse Events Associated with Hydroxychloroquine Reported to the United States Food and Drug Administration

Lipner SR, Wang Y.

Abstract:

Link to Article

SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS

Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, Bottiroli M, Mondino M, Merli M, Bellone A, Basile A, Ruggeri R, Colombo F, Moreno M, Pastori S, Perno CF, Tarsia P, Epis OM, Puoti M; Niguarda COVID-19 Working Group.

Abstract:

Link to Article

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, Zhou N, Petty LA, Baang JH, Dillman NO, Frame D, Gregg KS, Kaul DR, Nagel J, Patel TS, Zhou S, Lauring AS, Hanauer DA, Martin E, Sharma P, Fung CM, Pogue JM.

Abstract:

Link to Article

Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population

Yao X, Hou Z, Cui C, Zhang M, Tu S, Li H, Liu D.

Abstract:

Link to Article

That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19

Davis MR, McCreary EK, Pogue JM.

Abstract:

Link to Article

The role played by traditional Chinese medicine in preventing and treating COVID-19 in China

Li Q, Wang H, Li X, Zheng Y, Wei Y, Zhang P, Ding Q, Lin J, Tang S, Zhao Y, Zhao L, Tong X.

Abstract:

Link to Article

Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19

Schlom J, Donahue RN.

Abstract:

Link to Article

Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic

Crighton AJ, McCann CT, Todd EJ, Brown AJ.

Abstract:

Link to Article

Modification of existing occupational therapeutic protocols in response to new normal life after COVID 19: Letter to the Editor

Soheili S, Shariat A, Anastasio A.

Abstract:

Link to Article

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Park SH, Choi JY, Kim SH, Jung I, Shin EC.

Abstract:

Link to Article

Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal

Afra TP, Nampoothiri RV, Razmi T M, Hafi NAB.

Abstract:

Link to Article

Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial

Göpel S, Bethge W, Martus P, Kreth F, Iftner T, Joos S, Döbele S, Mordmüller B, Kremsner P, Ettrich T, Seufferlein T, Bitzer M, Malek N.

Abstract:

Link to Article

Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept

Valentini M, Zmerly H.

Abstract:

Link to Article

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19

Gade AR, Alavala H, Allam SR.

Abstract:

Link to Article

Personalized therapy approach for hospitalized patients with COVID-19

Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, Linares L, Rico V, Cardozo C, Martínez JA, García F, Mensa J, Castro P, Nicolás JM, Muñoz J, Vidal D, Soriano A; COVID19-Researchers.

Abstract:

Link to Article

Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria

Shanshal M.

Abstract:

Link to Article

Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply

Beigel JH, Tomashek KM, Dodd LE.

Abstract:

Link to Article

Remdesivir for the Treatment of Covid-19 - Preliminary Report

Olalla J.

Abstract:

Link to Article

Remdesivir for the Treatment of Covid-19 - Preliminary Report

McCaw ZR, Kim DH, Wei LJ.

Abstract:

Link to Article

Remdesivir for the Treatment of Covid-19 - Preliminary Report

McMahon JH, Udy A, Peleg AY.

Abstract:

Link to Article

Remdesivir for the Treatment of Covid-19 - Preliminary Report

Gillenwater S, Rahaghi F, Hadeh A.

Abstract:

Link to Article

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N.

Abstract:

Link to Article

SGLT2 inhibition and COVID-19: The road not taken

Das L, Dutta P.

Abstract:

Link to Article

COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use

Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD, Boes CJ, Whealy MA, VanderPluym JH.

Abstract:

Link to Article

[Exploration of fire needling therapy on coronavirus disease 2019]

Lin SY, Zhang YC, Wei YZ, Lin GH.

Abstract:

Link to Article

COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not

Akkoc T.

Abstract:

Link to Article

The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine

Sinkeler FS, Berger FA, Muntinga HJ, Jansen MMPM.

Abstract:

Link to Article

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19

Psaltopoulou T, Sergentanis TN, Pappa V, Politou M, Terpos E, Tsiodras S, Pavlakis GN, Dimopoulos MA.

Abstract:

Link to Article

Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making

Aquino YSJ, Cabrera N.

Abstract:

Link to Article

Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Mareno et al

Liew JW, Graef ER, Sparks JA, Kim AH.

Abstract:

Link to Article

Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

Santos-Moreno P, Buitrago-Garcia D, Villarreal L, Aza A, Cabrera M, Rivero W, Rojas-Villarraga A.

Abstract:

Link to Article

Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study

Potere N, Di Nisio M, Cibelli D, Scurti R, Frattari A, Porreca E, Abbate A, Parruti G.

Abstract:

Link to Article

Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1

Calabrese LH, Calabrese C.

Abstract:

Link to Article

Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project

Cutler CS, Bailey EA, Kumar V, Schwarz SW, Bom HH, Hatazawa J, Paez D, Orellana P, Louw L, Mut F, Kato H, Chiti A, Frangos S, Fahey FH, Dillehay G, Oh SJ, Lee DS, Lee ST, Nunez-Miller R, Bandopadhyaya GP, Pradhan P, Scott AM.

Abstract:

Link to Article

Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic

Abu-Raya B, Gantt S, Sadarangani M.

Abstract:

Link to Article

Vaccines, convalescent plasma, and monoclonal antibodies for covid-19

Sewell HF, Agius RM, Kendrick D, Stewart M.

Abstract:

Link to Article

Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab

Morrison AR, Johnson JM, Griebe KM, Jones MC, Stine JJ, Hencken LN, To L, Bianchini ML, Vahia AT, Swiderek J, Ramesh MS, Peters MA, Smith ZR.

Abstract:

Link to Article

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

Saiz-Rodríguez M, Peña T, Lázaro L, González Á, Martínez A, Cordero JA, Vicente JT, Richard F, Coma MJ, de Frutos M, Labrador J, Pueyo A.

Abstract:

Link to Article

Effect of favipiravir and an anti-inflammatory strategy for COVID-19

Yamamura H, Matsuura H, Nakagawa J, Fukuoka H, Domi H, Chujoh S.

Abstract:

Link to Article

Radiotherapy after the easing of public restrictions during COVID-19 epidemic

Wang W, Hu K, Qiu J, Zhang F.

Abstract:

Link to Article

Could Ergothioneine Aid in the Treatment of Coronavirus Patients?

Cheah IK, Halliwell B.

Abstract:

Link to Article

SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings

Kalra RS, Tomar D, Meena AS, Kandimalla R.

Abstract:

Link to Article

Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?

Prajapati S.

Abstract:

Link to Article

An update on antiviral antibody-based biopharmaceuticals

Ahangarzadeh S, Payandeh Z, Arezumand R, Shahzamani K, Yarian F, Alibakhshi A.

Abstract:

Link to Article

Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19

Zhang X, Zhang Y, Qiao W, Zhang J, Qi Z.

Abstract:

Link to Article

Hydroxychloroquine safety: A meta-analysis of randomized controlled trials

Eljaaly K, Alireza KH, Alshehri S, Al-Tawfiq JA.

Abstract:

Link to Article

SmartPDT®: smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy

McLellan LJ, Morelli M, Simeone E, Khazova M, Ibbotson SH, Eadie E.

Abstract:

Link to Article

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M, Li Y, Cheng H, Yuan Y, Zhang W, Ke C, Wong G, Qi J, Qin C, Yan J, Gao GF.

Abstract:

Link to Article

The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

Cappello M, Busacca A, Guida L.

Abstract:

Link to Article

Tocilizumab for COVID-19: a real 'miracle drug'?

Nasim S, Hashmi SH, Azim D, Kumar S, Nasim J.

Abstract:

Link to Article

Thinking more about therapy with convalescent plasma for COVID-19 patients

Han G, Zhou YH.

Abstract:

Link to Article

Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19

Alvi MM, Sivasankaran S, Singh M.

Abstract:

Link to Article

COVID-19 Clinical Diagnostics and Testing Technology

Chau CH, Strope JD, Figg WD.

Abstract:

Link to Article

Convalescent plasma therapy in patients with COVID-19

Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F.

Abstract:

Link to Article

Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease

Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM, Hadjiat Y, Eggers M.

Abstract:

Link to Article

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

Cingolani A, Tummolo AM, Montemurro G, Gremese E, Larosa L, Cipriani MC, Pasciuto G, Liperoti R, Murri R, Pirronti T, Cauda R, Fantoni M; for COVID 2 Columbus Working Group.

Abstract:

Link to Article

Addressing the "What do we have to lose? Just give the drug" rationale: making the case for clinical trials and against off-label use in COVID-19

Ramnath VR, Zar HJ, Malhotra A.

Abstract:

Link to Article

Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19

Raimondi MT, Donnaloja F, Barzaghini B, Bocconi A, Conci C, Parodi V, Jacchetti E, Carelli S.

Abstract:

Link to Article

A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic

Onchonga D.

Abstract:

Link to Article

Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management

Manoharan Y, Haridas V, Vasanthakumar KC, Muthu S, Thavoorullah FF, Shetty P.

Abstract:

Link to Article

Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update

Pal A, Pawar A, Goswami K, Sharma P, Prasad R.

Abstract:

Link to Article

BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?

Sharma A, Kumar Sharma S, Shi Y, Bucci E, Carafoli E, Melino G, Bhattacherjee A, Das G.

Abstract:

Link to Article

Is hydroxychloroquine beneficial for COVID-19 patients?

Li X, Wang Y, Agostinis P, Rabson A, Melino G, Carafoli E, Shi Y, Sun E.

Abstract:

Link to Article

Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial

Liu F, Zhu Y, Zhang J, Li Y, Peng Z.

Abstract:

Link to Article

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations

Marzolini C, Stader F, Stoeckle M, Franzeck F, Egli A, Bassetti S, Hollinger A, Osthoff M, Weisser M, Gebhard CE, Baettig V, Geenen J, Khanna N, Tschudin-Sutter S, Mueller D, Hirsch HH, Battegay M, Sendi P.

Abstract:

Link to Article

Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU

Duška F, Waldauf P, Halačová M, Zvoníček V, Bala J, Balík M, Beneš J, Klementová O, Kozáková I, Kubricht V, Le Roy A, Vymazal T, Řehořová V, Černý V; Czech Anaesthesia Clinical Trials and Audit Network.

Abstract:

Link to Article

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB.

Abstract:

Link to Article

Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

Liu X, Chen H, Shang Y, Zhu H, Chen G, Chen Y, Liu S, Zhou Y, Huang M, Hong Z, Xia J.

Abstract:

Link to Article

Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine

Sachdev U, Ferrari R, Cui X, Pius A, Sahu A, Reynolds M, Liao H, Sun P, Shinde S, Ambrosio F, Shiva S, Loughran P, Scott M.

Abstract:

Link to Article

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology

Jessica Chang TY, Pope JE.

Abstract:

Link to Article

Physician drug prescribing preferences and availability for ventilation of patients with COVID-19

Coombes ID, Dooley MJ, Townsend S, Carmichael S, Poole SG, Karamujic N, Richards B, Ziegenfuss M, Ankravs MJ, Uren H, Roberts JA, Holley A.

Abstract:

Link to Article

Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa?

Geisslinger F, Vollmar AM, Bartel K.

Abstract:

Link to Article

Current Therapies Under Investigation for COVID-19

Weisberg E Weisberg, Sattler M, Yang PL, Parent A, Gray N, Griffin JD.

Abstract:

Link to Article

Concentration-dependent mortality of chloroquine in overdose

Watson JA, Tarning J, Hoglund RM, Baud FJ, Megarbane B, Clemessy JL, White NJ.

Abstract:

Link to Article

Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19

Thierry AR.

Abstract:

Link to Article

Consideration of Tranexamic Acid Administration to COVID-19 Patients

Ogawa H, Asakura H.

Abstract:

Link to Article

Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID-19

Gatti M, Fusaroli M, Caraceni P, Poluzzi E, De Ponti F, Raschi E.

Abstract:

Link to Article

Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era

Alkan A, Uncu A, Taşkıran I, Tanrıverdi Ö.

Abstract:

Link to Article

QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19

Wu TC, Sacilotto L, Darrieux FCDC, Pisani CF, Melo SL, Hachul DT, Scanavacca M.

Abstract:

Link to Article

Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?

Biguetti C, Marrelli MT, Brotto M.

Abstract:

Link to Article

Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?

Mantero V, Rigamonti A, Basilico P, Crespi M, Balgera R, Salmaggi A.

Abstract:

Link to Article

Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System

Chang TS, Ding Y, Freund MK, Johnson R, Schwarz T, Yabu JM, Hazlett C, Chiang JN, Wulf A, Geschwind DH, Butte MJ, Pasaniuc B.

Abstract:

Link to Article

COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations

A R M, J J B, S A R M, S M J M.

Abstract:

Link to Article

Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients

Suwanwongse K, Shabarek N.

Abstract:

Link to Article

A severe refractory COVID-19 patient responding to convalescent plasma; A case series

Abdullah HM, Hama-Ali HH, Ahmed SN, Ali KM, Karadakhy KA, Mahmood SO, Mahmood ZH, Hamad Amin KQ, Atta PM, Nuradeen BE, Mohammed SH, Salih RQ, Baba HO, Kakamad FH.

Abstract:

Link to Article

Can vitamins and/or supplements provide hope against coronavirus?

Michienzi SM, Badowski ME.

Abstract:

Link to Article

Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)

Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE.

Abstract:

Link to Article

The Potential Beneficial Effect of EPA and DHA Supplementation Managing Cytokine Storm in Coronavirus Disease

Szabó Z, Marosvölgyi T, Szabó É, Bai P, Figler M, Verzár Z.

Abstract:

Link to Article

Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19

Belladonna ML, Orabona C.

Abstract:

Link to Article

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

Funk CD, Laferrière C, Ardakani A.

Abstract:

Link to Article

COVID-19 platform trial delivers

Mullard A.

Abstract:

Link to Article

Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption

Yiğenoğlu TN, Ulas T, Dal MS, Korkmaz S, Erkurt MA, Altuntaş F.

Abstract:

Link to Article

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19

Goker Bagca B, Biray Avci C.

Abstract:

Link to Article

Covid-19 treatment-induced neuropsychiatric adverse effects

García CAC, Sánchez EBA, Huerta DH, Gómez-Arnau J.

Abstract:

Link to Article

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cumhur Cure M, Kucuk A, Cure E.

Abstract:

Link to Article

Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review

Farooqi F, Dhawan N, Morgan R, Dinh J, Nedd K, Yatzkan G.

Abstract:

Link to Article

Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design

Wang D, Mai J, Zhou W, Yu W, Zhan Y, Wang N, Epstein ND, Yang Y.

Abstract:

Link to Article

COVID-19 Treatment: Close to a Cure? - A Rapid Review of Pharmacotherapies for the Novel Coronavirus

Song Y, Zhang M, Yin L, Wang K, Zhou Y, Zhou M, Lu Y.

Abstract:

Link to Article

Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study

Bani-Sadr F, Hentzien M, Pascard M, N'guyen Y, Servettaz A, Andreoletti L, Kanagaratnam L, Jolly D.

Abstract:

Link to Article

Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy

Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K.

Abstract:

Link to Article

Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review

Torabi R, Ranjbar R, Halaji M, Heiat M.

Abstract:

Link to Article

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

Omolo CA, Soni N, Fasiku VO, Mackraj I, Govender T.

Abstract:

Link to Article

Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19)

Lovato ECW, Barboza LN, Wietzikoski S, de Souza ANV, Auth PA, Junior AG, Dos Reis Lívero FA.

Abstract:

Link to Article

The role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases

Martinez GP, Zabaleta ME, Di Giulio C, Charris JE, Mijares MR.

Abstract:

Link to Article

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

McCaw ZR, Tian L, Vassy JL, Ritchie CS, Lee CC, Kim DH, Wei LJ.

Abstract:

Link to Article

A Retrospective Review of Memantine Use and COVID-19-associated Mortality from a National Database

Park MH, Kwon DY.

Abstract:

Link to Article

Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations

Procacci P, Macchiagodena M, Pagliai M, Guarnieri G, Iannone F.

Abstract:

Link to Article

A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm

Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, Mast AE, Justice A, Aronow B, Jacobson D.

Abstract:

Link to Article

Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy

Sardu C, Maggi P, Messina V, Iuliano P, Sardu A, Iovinella V, Paolisso G, Marfella R.

Abstract:

Link to Article

Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past?

Franceschi F, Gasbarrini G, Gasbarrini A.

Abstract:

Link to Article

Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari "Aldo Moro" in Italy

Pham VH, Gargiulo Isacco C, Nguyen KCD, Le SH, Tran DK, Nguyen QV, Pham HT, Aityan S, Pham ST, Cantore S, Inchingolo AM, Inchingolo AD, Dipalma G, Ballini A, Inchingolo F.

Abstract:

Link to Article

A nation-wide survey on emotional and psychological impacts of COVID-19 social distancing

Cerbara L, Ciancimino G, Crescimbene M, La Longa F, Parsi MR, Tintori A, Palomba R.

Abstract:

Link to Article

COVID-19 with bronchogram - a potential indication of prolonged treatment

Qian WJ, Li L, Sun LY, Shi HR, Liu H, Jing X.

Abstract:

Link to Article

The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43

Soltani S.

Abstract:

Link to Article

Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends

Kannan S, Shaik Syed Ali Pakeer P, Sheeza Ali A, Hemalatha K.

Abstract:

Link to Article

The complement inhibitors in COVID-19: future expectations

Korotchaeva Y, Kozlovskaya N, Bobrova L, Kamyshova E, Demyanova K, Moiseev S.

Abstract:

Link to Article

How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?

Fabi A, Ferretti G, Cognetti F.

Abstract:

Link to Article

Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature

Mansouri N, Marjani M, Tabarsi P, von Garnier C, Mansouri D.

Abstract:

Link to Article

Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review

Sohag AAM, Hannan MA, Rahman S, Hossain M, Hasan M, Khan MK, Khatun A, Dash R, Uddin MJ.

Abstract:

Link to Article

The treatment and follow-up of "recurrence" with discharged COVID-19 patients: Data from Guizhou, China

Tian M, Long Y, Hong Y, Zhang X, Zha Y.

Abstract:

Link to Article

Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?

Zaitoun MMA, Basha MAA, Elmokadem AH.

Abstract:

Link to Article

The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond

Tramontana F, Napoli N, El-Hajj Fuleihan G, Strollo R.

Abstract:

Link to Article

In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking

Gao LQ, Xu J, Chen SD.

Abstract:

Link to Article

COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution

Molento MB.

Abstract:

Link to Article

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention

Nasi A, McArdle S, Gaudernack G, Westman G, Melief C, Rockberg J, Arens R, Kouretas D, Sjölin J, Mangsbo S.

Abstract:

Link to Article

Should patients starting biologics be screened for COVID-19?

Cardenas-de la Garza JA, Arvizu-Rivera RI, Galarza-Delgado DA.

Abstract:

Link to Article

Fan therapy for cough: case report and literature review

Sutherland AE, Carey M, Miller M.

Abstract:

Link to Article

JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

Mehta P, Ciurtin C, Scully M, Levi M, Chambers RC.

Abstract:

Link to Article

Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2

Skayem C, Ayoub N.

Abstract:

Link to Article

Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?

Garraud O.

Abstract:

Link to Article

Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial

Beigmohammadi MT, Bitarafan S, Hoseindokht A, Abdollahi A, Amoozadeh L, Mahmoodi Ali Abadi M, Foroumandi M.

Abstract:

Link to Article

Guidance concerning chiropractic practice in response to COVID-19 in the U.S.: a summary of state regulators' web-based information

Neff SM, Roecker CB, Okamoto CS, Holguin SL, Napuli JG, Mattox R, Hinkeldey NA, Paris DJ.

Abstract:

Link to Article

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19

Leow MKS.

Abstract:

Link to Article

Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19

Naghipour S, Ghodousi M, Rahsepar S, Elyasi S.

Abstract:

Link to Article

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening

Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM, Cretu O.

Abstract:

Link to Article

Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection

Palmeira A, Sousa E, Köseler A, Sabirli R, Gören T, Türkçüer İ, Kurt Ö, Pinto MM, Vasconcelos MH.

Abstract:

Link to Article

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review

Santos J, Brierley S, Gandhi MJ, Cohen MA, Moschella PC, Declan ABL.

Abstract:

Link to Article

Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy

Cavagna L, Seminari E, Zanframundo G, Gregorini M, Di Matteo A, Rampino T, Montecucco C, Pelenghi S, Cattadori B, Pattonieri EF, Vitulo P, Bertani A, Sambataro G, Vancheri C, Biglia A, Bozzalla-Cassione E, Bonetto V, Monti MC, Ticozzelli E, Turco A, Oggionni T, Corsico A, Bertuccio F, Zuccaro V, Codullo V, Morosini M, Marena C, Gnecchi M, Pellegrini C, Meloni F.

Abstract:

Link to Article

Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives

Meini S, Pagotto A, Longo B, Vendramin I, Pecori D, Tascini C.

Abstract:

Link to Article

Acupuncture for breathlessness in COVID-19: A protocol for systematic review and meta-analysis

Zhang B, Zhang K, Tang Q, Sun K, Han Z.

Abstract:

Link to Article

COVID19 inhibitors: A prospective therapeutics

Jawaid Akhtar M.

Abstract:

Link to Article

Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges

Chang R, Sun WZ.

Abstract:

Link to Article

Janus sword actions of chloroquine and hydroxychloroquine against COVID-19

Chen X, Geiger JD.

Abstract:

Link to Article

No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"

Lebeaux D, Revest M.

Abstract:

Link to Article

A pharmacological perspective of Chloroquine in SARS-CoV-2 infection

Oscanoa TJ, Romero-Ortuno R, Carvajal A, Savarino A.

Abstract:

Link to Article

Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2

Pagano A, Porta G, Bosso G, Allegorico E, Serra C, Dello Vicario F, Minerva V, Russo T, Altruda C, Arbo P, Numis FG.

Abstract:

Link to Article

The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide

Yamasaki Y, Ooka S, Tsuchida T, Nakamura Y, Hagiwara Y, Naitou Y, Ishibashi Y, Ikeda H, Sakurada T, Handa H, Nishine H, Takita M, Morikawa D, Yoshida H, Fujii S, Morisawa K, Takemura H, Fujitani S, Kunishima H.

Abstract:

Link to Article

Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: experience from Humanitas Center, Milan

Allocca M, Guidelli GM, Borroni RG, Selmi C, Narcisi A, Danese S, Fiorino G.

Abstract:

Link to Article

Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics

Chang CY, Chan KG.

Abstract:

Link to Article

The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity

Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G.

Abstract:

Link to Article

Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective

Mansuri Z, Shah B, Trivedi C, Beg U, Patel H, Jolly T.

Abstract:

Link to Article

The Development of COVID-19 Vaccines: Safeguards Needed

Lurie N, Sharfstein JM, Goodman JL.

Abstract:

Link to Article

US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020

Shehab N, Lovegrove M, Budnitz DS.

Abstract:

Link to Article

Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections

Soriano V, Barreiro P.

Abstract:

Link to Article

Analytical Methods on Determination in Pharmaceuticals and Biological Materials of Chloroquine as Available for the Treatment of COVID-19

Saka C.

Abstract:

Link to Article

Tocilizumab in patients with severe COVID-19: A single-center observational analysis

Knorr JP, Colomy V, Mauriello CM, Ha S.

Abstract:

Link to Article

Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses

Kim KD, Hwang I, Ku KB, Lee S, Kim SJ, Kim C.

Abstract:

Link to Article

Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles

Im JH, Nahm CH, Baek JH, Kwon HY, Lee JS.

Abstract:

Link to Article

Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation

Li L, Tong X, Chen H, He R, Lv Q, Yang R, Zhao L, Wang J, Xu H, Liu C, Chen G, Chen S, Li C, Qiao J, Yang J, Wu Y, Liu Z.

Abstract:

Link to Article

Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review

Abdelmaseih R, Abdelmasih R, Hasan M, Tadepalli S, Patel J.

Abstract:

Link to Article

COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby

Fujiwara K, Quinn MA.

Abstract:

Link to Article

Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19

Guzman-Prado Y.

Abstract:

Link to Article

Cardiac arrest precipitated by succinylcholine in a patient with COVID-19. Comment on Br J Anaesth 2020; 10.1016/j.bja.2020.04.073

Crockett DC, Frise MC, Strachan JM.

Abstract:

Link to Article

Is shortening the response-to-treatment waiting time appropriate during the Covid-19 pandemic?

Silberberg A, Monteros Alvi N, Ocampos J, Quiñónez F.

Abstract:

Link to Article

Going back in time for an antibody to fight COVID-19

Whittaker GR, Daniel S.

Abstract:

Link to Article

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

Jiménez-Alberto A, Ribas-Aparicio RM, Aparicio-Ozores G, Castelán-Vega JA.

Abstract:

Link to Article

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, Brar I, Alangaden GJ, Ramesh MS, McKinnon JE, O'Neill W, Zervos M; Henry Ford COVID-19 Task Force.

Abstract:

Link to Article

An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction

Lee TC, MacKenzie LJ, McDonald EG, Tong SYC.

Abstract:

Link to Article

Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk

Offerhaus JA, Wilde AAM, Remme CA.

Abstract:

Link to Article

The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic

Syed MN, Shin DB, Wan MT, Winthrop KL, Gelfand JM.

Abstract:

Link to Article

(Vi)-rushed Into Online Group Schema Therapy Based Day-Treatment for Older Adults by the COVID-19 Outbreak in the Netherlands

van Dijk SDM, Bouman R, Folmer EH, den Held RC, Warringa JE, Marijnissen RM, Voshaar RCO.

Abstract:

Link to Article

Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis

Xiong X, Wang P, Su K, Cho WC, Xing Y.

Abstract:

Link to Article

Is Inhaled Furosemide a Potential Therapeutic for COVID-19?

Brennecke A, Villar L, Wang Z, Doyle LM, Meek A, Reed M, Barden C, Weaver DF.

Abstract:

Link to Article

Current Status of COVID-19 Therapies and Drug Repositioning Applications

Altay O, Mohammadi E, Lam S, Turkez H, Boren J, Nielsen J, Uhlen M, Mardinoglu A.

Abstract:

Link to Article

Azithromycin and SARS-CoV-2 infection: where we are now and where we are going

Parra-Lara LG, Martínez-Arboleda JJ, Rosso F.

Abstract:

Link to Article

Early combination of Tocilizumab and Corticosteroids: An upgrade in anti-inflammatory therapy for severe COVID

Martínez-Urbistondo D, Costa Segovia R, Suárez Del Villar Carrero R, Risco Risco C, Villares Fernández P.

Abstract:

Link to Article

Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study

Yu C, Zhang Z, Guo Y, Shi J, Pei G, Yao Y, Liao W, Zeng R.

Abstract:

Link to Article

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

Xu J, Huang C, Fan G, Liu Z, Shang L, Zhou F, Wang Y, Yu J, Yang L, Xie K, Huang Z, Huang L, Gu X, Li H, Zhang Y, Wang Y, Hayden FG, Horby PW, Cao B, Wang C.

Abstract:

Link to Article

Low Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care

H√∏ilund-Carlsen PF, Braad PE, Gerke O, Iversen KK, Vach W.

Abstract:

Link to Article

Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?

Yalçın N, Ak S, Demirkan K.

Abstract:

Link to Article

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF Study Group; SARI-RAF Study Group members.

Abstract:

Link to Article

Dexamethasone in the management of covid -19

Johnson RM, Vinetz JM.

Abstract:

Link to Article

CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges

Hu Y, Tan Su Yin E, Yang Y, Wu H, Wei G, Su J, Cui Q, Jin A, Yang L, Fu S, Zhou J, Qiu L, Zhang X, Liang A, Jing H, Li Y, Blaise D, Mohty M, Nagler A, Huang H.

Abstract:

Link to Article

Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

Erkurt MA, Sarici A, Berber İ, Kuku İ, Kaya E, Özgül M.

Abstract:

Link to Article

Contingent assessment of the COVID-19 vaccine

García LY, Cerda AA.

Abstract:

Link to Article

Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic

Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M.

Abstract:

Link to Article

Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series

Doi K, Ikeda M, Hayase N, Moriya K, Morimura N; COVID-UTH Study Group.

Abstract:

Link to Article

The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trial

Nasb M, Sayed Shah ZA, Huang L, Li Q, Chen H.

Abstract:

Link to Article

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA.

Abstract:

Link to Article

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Houot R, Levy R, Cartron G, Armand P.

Abstract:

Link to Article

Case reports study of the first five patients COVID-19 treated with remdesivir in France

Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX.

Abstract:

Link to Article

Associations of Clinical Characteristics and Treatment Regimens with Viral RNA Shedding Duration in Patients with COVID-19

Chen X, Zhu B, Hong W, Zeng J, He X, Chen J, Zheng H, Qiu S, Deng Y, Chan JC, Wang J, Zhang Y.

Abstract:

Link to Article

Edaravone: a potential treatment for the COVID-19-induced inflammatory syndrome?

Reznik SE, Tiwari AK, Ashby CR Jr.

Abstract:

Link to Article

Mortality in COVID-19 patients treated with ACEIs/ARBs: re-estimated meta-analysis results following the Mehra et al. retraction

Alamer A, Abraham I.

Abstract:

Link to Article

CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2

Martin R, Löchel HF, Welzel M, Hattab G, Hauschild AC, Heider D.

Abstract:

Link to Article

Willingness to vaccinate against COVID-19 in Australia

Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ; Sydney Health Literacy Lab COVID-19 group.

Abstract:

Link to Article

COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates

Ulm JW, Nelson SF.

Abstract:

Link to Article

Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity?

Mortazavi S, Kefayat A, Cai J.

Abstract:

Link to Article

Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review

Idrees M, Khan S, Memon NH, Zhang Z.

Abstract:

Link to Article

Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)

Naqvi M, Zakowski P, Glucksman L, Smithson S, Burwick RM.

Abstract:

Link to Article

Testing COVID-19 therapies to prevent progression of mild disease

Lipsitch M, Perlman S, Waldor MK.

Abstract:

Link to Article

Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights

Stoian AP, Papanas N, Prazny M, Rizvi AA, Rizzo M.

Abstract:

Link to Article

Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Huang D, Yu H, Wang T, Yang H, Yao R, Liang Z.

Abstract:

Link to Article

Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review

Singh SP, Pritam M, Pandey B, Yadav TP.

Abstract:

Link to Article

Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence

Teoh N, Farrell G.

Abstract:

Link to Article

Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report

Davoodi L, Jafarpour H, Kazeminejad A, Soleymani E, Akbari Z, Razavi A.

Abstract:

Link to Article

BET 2: Hydroxychloroquine in the treatment of COVID-19

Howard L, Baombe J, Reynard C.

Abstract:

Link to Article

BET 1: Lopinavir-ritonavir and COVID-19

Dolan D, Ingham J, Baombe J.

Abstract:

Link to Article

Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia

Holm S.

Abstract:

Link to Article

Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey

Plüß M, Chehab G, Korsten P.

Abstract:

Link to Article

Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß et al

Mathian A, Amoura Z.

Abstract:

Link to Article

A critical evaluation of glucocorticoids in the management of severe COVID-19

Solinas C, Perra L, Aiello M, Migliori E, Petrosillo N.

Abstract:

Link to Article

The influence of corticosteroid on patients with COVID-19 infection: A meta-analysis

Wang Y, Ao G, Qi X, Zeng J.

Abstract:

Link to Article

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

McEniery CM, Fisk M, Miles K, Kaloyirou F, Vamvaka E, Hubsch A, Smith J, Wilkinson IB, Cheriyan J.

Abstract:

Link to Article

Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial

González R, García-Otero L, Pons-Duran C, Marbán-Castro E, Goncé A, Llurba E, Del Mar Gil M, Rodríguez-Zambrano MÁ, Chen H, Ramírez M, Bardají A, Menendez C.

Abstract:

Link to Article

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Pranata R, Permana H, Huang I, Lim MA, Soetedjo NNM, Supriyadi R, Soeroto AY, Alkatiri AA, Firman D, Lukito AA.

Abstract:

Link to Article

Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19

El-Missiry MA, El-Missiry ZM, Othman AI.

Abstract:

Link to Article

Ivermectin: potential candidate for the treatment of Covid 19

Gupta D, Sahoo AK, Singh A.

Abstract:

Link to Article

Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments

Venisse N.

Abstract:

Link to Article

Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge

Levy JM.

Abstract:

Link to Article

Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia

Top KA, Macartney K, Bettinger JA, Tan B, Blyth CC, Marshall HS, Vaudry W, Halperin SA, McIntyre P; IMPACT and PAEDS investigators.

Abstract:

Link to Article

Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19

Tutunchi H, Naeini F, Ostadrahimi A, Hosseinzadeh-Attar MJ.

Abstract:

Link to Article

Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial

Algara M, Arenas M, Marin J, Vallverdu I, Fernandez-Letón P, Villar J, Fabrer G, Rubio C, Montero A.

Abstract:

Link to Article

Strategy for Disease Diagnosis, Progression Prediction, Risk Group Stratification and Treatment-Case of COVID-19

Vihinen M.

Abstract:

Link to Article

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

Bishara D, Kalafatis C, Taylor D.

Abstract:

Link to Article

Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy

Poulas K, Farsalinos K, Zanidis C.

Abstract:

Link to Article

Clinical management of COVID-19

Varghese GM, John R, Manesh A, Karthik R, Abraham OC.

Abstract:

Link to Article

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19

Gambichler T, Reuther J, Scheel CH, Becker JC.

Abstract:

Link to Article

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

Flacco ME, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, Manfredini R, Mantovani LG, Manzoli L.

Abstract:

Link to Article

Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds

Griffin S.

Abstract:

Link to Article

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

de Castro CG Jr, Gregianin LJ, Burger JA.

Abstract:

Link to Article

Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?

Udwadia ZF, Malu KN, Rana D, Joshi SR.

Abstract:

Link to Article

Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study

Bhandari S, Singh A, Sharma R, Rankawat G, Banerjee S, Gupta V, Dube A, Kakkar S, Sharma S, Keswani P, Agrawal A, Tak A, Nawal CL.

Abstract:

Link to Article

Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective

Singh AK, Majumdar S, Singh R, Misra A.

Abstract:

Link to Article

Effects of Hydroxychloroquine Treatment on QT Interval

Hooks M, Bart B, Vardeny O, Westanmo A, Adabag S.

Abstract:

Link to Article

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling

Maggioni AP, Andreotti F, Gervasoni C, Di Pasquale G.

Abstract:

Link to Article

Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells

Stanifer ML, Kee C, Cortese M, Zumaran CM, Triana S, Mukenhirn M, Kraeusslich HG, Alexandrov T, Bartenschlager R, Boulant S.

Abstract:

Link to Article

Mitigate risks of medication interruption due to COVID-19 for elderly with chronic diseases

Hsiao SH, Chang HM, Kang YT, Chen YH.

Abstract:

Link to Article

Overmedication in COVID-19 context: a report from Peru

Martinez-Rivera RN, Taype-Rondan A.

Abstract:

Link to Article

COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

Bénézit F, Le Bot A, Jouneau S, Lemaître F, Pronier C, Lentz PA, Patrat-Delon S, Revest M, Thibault V, Tattevin P.

Abstract:

Link to Article

[In-hospital treatment of COVID-19 patients]

de Wee EM, van der Sar-van der Brugge S, Grootenboers M, Bentvelsen RG, Kant KM, van der Leest CH.

Abstract:

Link to Article

COVID-19 Et vaccination contre la grippe: l’équation française

Nau JY.

Abstract:

Link to Article

Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?

Luxenburger H, Sturm L, Biever P, Rieg S, Duerschmied D, Schultheiss M, Neumann-Haefelin C, Thimme R, Bettinger D.

Abstract:

Link to Article

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?

Abobaker A.

Abstract:

Link to Article

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Patel TK, Barvaliya M, Kevadiya BD, Patel PB, Bhalla HL.

Abstract:

Link to Article

Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

Tempestilli M, Caputi P, Avataneo V, Notari S, Forini O, Scorzolini L, Marchioni L, Ascoli Bartoli T, Castilletti C, Lalle E, Capobianchi MR, Nicastri E, D'Avolio A, Ippolito G, Agrati C.

Abstract:

Link to Article

Influenza Vaccination and COVID19 Mortality in the USA

Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L.

Abstract:

Link to Article

Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19

Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, McNeil C, Feng R, Guzman G, Abdelwahab N, King S, Meehan T, Benson B, Pendleton K, Vojta D, Tignanelli CJ.

Abstract:

Link to Article

Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest

Hartman W, Hess AS, Connor JP.

Abstract:

Link to Article

Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, Hall MD.

Abstract:

Link to Article

Coronaviruses' sugar shields as vaccine candidates

Wang D.

Abstract:

Link to Article

COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach

Cheng F, Rao S, Mehra R.

Abstract:

Link to Article

Drug misuse rose 30% in past decade and covid-19 could worsen situation, UN report warns

O'Dowd A.

Abstract:

Link to Article

Role of vitamin D in preventing of COVID-19 infection, progression and severity

Ali N.

Abstract:

Link to Article

Successful treatment of coronavirus disease 2019 in a patient with asthma

Joshi AY, Mullakary RM, Iyer VN.

Abstract:

Link to Article

Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas

Enzmann MO, Erickson MP, Grindeland CJ, Lopez SMC, Hoover SE, Leedahl DD.

Abstract:

Link to Article

COVID-19, Medication-Assisted Treatment, and Increased Risk for Further Respiratory Depression

Boyer J.

Abstract:

Link to Article

Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives

Boukhatem MN, Setzer WN.

Abstract:

Link to Article

Application of Social Network Analysis of COVID-19 Related Tweets Mentioning Cannabis and Opioids to Gain Insights for Drug Abuse Research

Yoon S, Odlum M, Broadwell P, Davis N, Cho H, Deng N, Patrao M, Schauer D, Bales ME, Alcantara C.

Abstract:

Link to Article

Antenatal Corticosteroids for Pregnant Women at High Risk of Preterm Delivery with COVID-19 Infection: A Decision Analysis

Packer CH, Zhou CG, Hersh AR, Allen AJ, Hermesch AC, Caughey AB.

Abstract:

Link to Article

Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention

Hall MW, Joshi I, Leal L, Ooi EE.

Abstract:

Link to Article

Therapeutic Potential of B-1a Cells in COVID-19

Aziz M, Brenner M, Wang P.

Abstract:

Link to Article

Influenza vaccination in the COVID-19 era

Grech V, Borg M.

Abstract:

Link to Article

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic

Emmanuel S, Östlundh L.

Abstract:

Link to Article

Could the COVID-19 pandemic aggravate antimicrobial resistance?

Rossato L, Negr√£o FJ, Simionatto S.

Abstract:

Link to Article

Corticosteroid administration for viral pneumonia: COVID-19 and beyond

Yang JW, Yang L, Luo RG, Xu JF.

Abstract:

Link to Article

Targeting inflammation and cytokine storm in COVID-19

Huang Q, Wu X, Zheng X, Luo S, Xu S, Weng J.

Abstract:

Link to Article

Using Cyclosporine in the COVID era: an emergent need for caution

Khurana A, Sethia K.

Abstract:

Link to Article

Current pharmacological treatments for SARS-COV-2: A narrative review

Nittari G, Pallotta G, Amenta F, Tayebati SK.

Abstract:

Link to Article

Calcineurin inhibitors revisited: A new paradigm for COVID-19?

Hage R, Steinack C, Schuurmans MM.

Abstract:

Link to Article

Covid-19, Cocooning and Vitamin D Intake Requirements

McKenna MJ, Flynn MAT.

Abstract:

Link to Article

Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial

Davoodi L, Abedi SM, Salehifar E, Alizadeh-Navai R, Rouhanizadeh H, Khorasani G, Hosseinimehr SJ.

Abstract:

Link to Article

Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study

Sanz Herrero F, Puchades Gimeno F, Ortega García P, Ferrer Gómez C, Ocete Mochón MD, García Deltoro M.

Abstract:

Link to Article

Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments

Lemaitre F, Solas C, Grégoire M, Lagarce L, Elens L, Polard E, Saint-Salvi B, Sommet A, Tod M, Barin-Le Guellec C; French Society of Pharmacology, Therapeutics (SFPT), the International Association of Therapeutic Drug Monitoring, Clinical Toxicology (IATDMCT).

Abstract:

Link to Article

Systematic Review and Meta-Analysis of the Efficacy of Nanoscale Materials Against Coronaviruses-Possible Potential Antiviral Agents for SARS-CoV-2

Alizadeh F, Khodavandi A.

Abstract:

Link to Article

COVID-19 and Remdesivir, Insulin Analogues, Opioid Use Disorder, Urinary Incontinence

Abstract:

Link to Article

The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the question

Cirino G, Ahluwalia A.

Abstract:

Link to Article

Convalescent Plasma Therapy: Helpful Treatment of COVID-19 in a Kidney Transplant Recipient presenting with serve clinical manifestation and complex complications

Jiang J, Miao Y, Zhao Y, Lu X, Zhou P, Zhou X, Chen Z, Du D.

Abstract:

Link to Article

Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection

Tan HW, Xu YM, Lau ATY.

Abstract:

Link to Article

Ruxolitinib for tocilizumab-refractory severe COVID-19 infection

Innes AJ, Cook LB, Marks S, Bataillard E, Crossette-Thambiah C, Sivasubramaniam G, Apperley J, Milojkovic D.

Abstract:

Link to Article

Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery

Clark E, Guilpain P, Filip L, Pansu N, Le Bihan C, Cartron G, Tchernonog E, Roubille C, Morquin D, Makinson A, Tuaillon E, Le Moing V.

Abstract:

Link to Article

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia

Conte WL.

Abstract:

Link to Article

Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods

Albahri OS, Al-Obaidi JR, Zaidan AA, Albahri AS, Zaidan BB, Salih MM, Qays A, Dawood KA, Mohammed RT, Abdulkareem KH, Aleesa AM, Alamoodi AH, Chyad MA, Zulkifli CZ.

Abstract:

Link to Article

Does PDT have potential in the treatment of COVID 19 patients?

Moghissi K, Dixon K, Gibbins S.

Abstract:

Link to Article

Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19

Bose RJ, McCarthy JR.

Abstract:

Link to Article

Emerging vaccine delivery systems for COVID-19: Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine

Theobald N.

Abstract:

Link to Article

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

Esam Z.

Abstract:

Link to Article

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

Li C, Wang L, Ren L.

Abstract:

Link to Article

Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?

Bailly C, Vergoten G.

Abstract:

Link to Article

Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia

Cantini F, Niccoli L, Nannini C, Matarrese D, Natale MED, Lotti P, Aquilini D, Landini G, Cimolato B, Pietro MAD, Trezzi M, Stobbione P, Frausini G, Navarra A, Nicastri E, Sotgiu G, Goletti D.

Abstract:

Link to Article

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, Lei F, Chen MM, Yang H, Bai L, Song X, Lin L, Xia M, Zhou F, Zhou J, She ZG, Zhu L, Ma X, Xu Q, Ye P, Chen G, Liu L, Mao W, Yan Y, Xiao B, Lu Z, Peng G, Liu M, Yang J, Yang L, Zhang C, Lu H, Xia X, Wang D, Liao X, Wei X, Zhang BH, Zhang X, Yang J, Zhao GN, Zhang P, Liu PP, Loomba R, Ji YX, Xia J, Wang Y, Cai J, Guo J, Li H.

Abstract:

Link to Article

Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story

Stoian AP, Catrinoiu D, Rizzo M, Ceriello A.

Abstract:

Link to Article

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

Siccardi M, Schapiro J, Di Perri G, Back DJ.

Abstract:

Link to Article

Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?

Wright C, Ross C, Mc Goldrick N.

Abstract:

Link to Article

SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds

Moore JP, Klasse PJ.

Abstract:

Link to Article

Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Rycroft AN, Smith KC, Noad R, Werling D.

Abstract:

Link to Article

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al

Monti S, Montecucco C.

Abstract:

Link to Article

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A.

Abstract:

Link to Article

Supportive treatment of COVID 19 patients with mild respiratory failure in a primary hospital

Martín Raymondi D, Hernández L.

Abstract:

Link to Article

Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm

Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Morales-Ortiz A, Meca-Lallana JE.

Abstract:

Link to Article

ACTH 1-24 and other melanocortins for COVID-19 treatment

Bertolini A, Noera G.

Abstract:

Link to Article

Remdesivir Receives Emergency Use Authorization for Severely Ill Patients with COVID-19

Aschenbrenner DS.

Abstract:

Link to Article

Nitric Oxide dosed in short bursts at high concentrations may protect against Covid 19

Hedenstierna G, Chen L, Hedenstierna M, Lieberman R, Fine DH.

Abstract:

Link to Article

The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19

Huang YX, Wang WX, Zhang S, Tang YP, Yue SJ.

Abstract:

Link to Article

Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID-19, in Healthy Subjects

Humeniuk R, Mathias A, Cao H, Osinusi A, Shen G, Chng E, Ling J, Vu A, German P.

Abstract:

Link to Article

Immunosuppression drug advice and COVID-19: are we doing more harm than good?

Warraich R, Amani L, Mediwake R, Tahir H.

Abstract:

Link to Article

Current State of Research About Chinese Herbal Medicines (CHM) for the Treatment of Coronavirus Disease 2019 (COVID-19): A Scoping Review

López-Alcalde J, Yan Y, Witt CM, Barth J.

Abstract:

Link to Article

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Smolders EJ, Te Brake LH, Burger DM.

Abstract:

Link to Article

Statistical Issues and Lessons Learned from COVID-19 Clinical Trials with Lopinavir-Ritonavir and Remdesivir

Yin G, Zhang C, Jin H.

Abstract:

Link to Article

Vesicular drug-delivery systems as theranostics in COVID-19

Satija S, Mehta M, Sharma M, Prasher P, Gupta G, Chellappan DK, Dua K.

Abstract:

Link to Article

High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19

Li S, Hu Z, Song X.

Abstract:

Link to Article

QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection

Bun SS, Taghji P, Courjon J, Squara F, Scarlatti D, Theodore G, Baudouy D, Sartre B, Labbaoui M, Dellamonica J, Doyen D, Marquette CH, Levraut J, Esnault V, Bun SS, Ferrari E.

Abstract:

Link to Article

Corticosteroids in diabetes patients infected with COVID-19

Deng F, Gao D, Ma X, Guo Y, Wang R, Jiang W, Gong S.

Abstract:

Link to Article

Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?"

Cure E, Cumhur Cure M, Kucuk A.

Abstract:

Link to Article

COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis

Mantero V, Abate L, Basilico P, Balgera R, Salmaggi A, Nourbakhsh B, Cordano C.

Abstract:

Link to Article

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia

Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A.

Abstract:

Link to Article

A potential role for Galectin-3 inhibitors in the treatment of COVID-19

Caniglia JL, Guda MR, Asuthkar S, Tsung AJ, Velpula KK.

Abstract:

Link to Article

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

Maarouf A, Rico A, Boutiere C, Perriguey M, Demortiere S, Pelletier J, Audoin B; Under the aegis of OFSEP.

Abstract:

Link to Article

Inhibition of SARS-CoV-2 by type I and type III interferons

Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F.

Abstract:

Link to Article

COvid MEdicaTion (COMET) study: protocol for a cohort study

Sablerolles RSG, Hogenhuis FEF, Lafeber M, van de Loo BPA, Borgsteede SD, Boersma E, Versmissen J, van der Kuy HM; COMET Research team.

Abstract:

Link to Article

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Jovani V, Calabuig I, Peral-Garrido ML, Tovar-Sugrañes E, López-González MD, Bernabeu P, Martínez A, Esteve-Vives J, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link to Article

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments

Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O.

Abstract:

Link to Article

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Mendel A, Bernatsky S, Askanase A, Bae SC, Clarke AE, Costedoat-Chalumeau N, Gladman DD, Gordon C, Hanly J, Jacobsen S, Kalunian K, Mak A, Mosca M, Pons-Estel BA, Ruiz-Irastorza G, Urowitz M, Vinet É.

Abstract:

Link to Article

Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial

Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I.

Abstract:

Link to Article

A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial"

Tornero C, Vallejo R, Cedeño D, Orduña J, Pastor E, Belaouchi M, Escamilla B, Laredo M, Del Mar Garzando M.

Abstract:

Link to Article

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R; COVID-19 HD Study Group.

Abstract:

Link to Article

Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)

Kim J, Zhang J, Cha Y, Kolitz S, Funt J, Escalante Chong R, Barrett S, Kusko R, Zeskind B, Kaufman H.

Abstract:

Link to Article

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial

Allahyari A, Rahimi H, Khadem-Rezaiyan M, Mozaheb Z, Seddigh-Shamsi M, Bary A, Kamandi M, Azimi SA, HasanAbadi SE, Noferesti A, Shariatmaghani SS, Rafatpanah H, Khatami S, Imani AJ, Mortazi H, Nodeh MM.

Abstract:

Link to Article

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19

Torneri A, Libin P, Vanderlocht J, Vandamme AM, Neyts J, Hens N.

Abstract:

Link to Article

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

McFadyen JD, Stevens H, Peter K.

Abstract:

Link to Article

Montelukast's ability to fight COVID-19 infection

Bozek A, Winterstein J.

Abstract:

Link to Article

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries

Elshabrawy HA.

Abstract:

Link to Article

Emerging Prevention and Treatment Strategies to Control COVID-19

Singh VK, Mishra A, Singh S, Kumar P, Singh M, Jagannath C, Khan A.

Abstract:

Link to Article

A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient

Thammathiwat T, Tungsanga S, Tiankanon K, Torvorapanit P, Chumpangern W, Udomkarnjananun S, Avihingsanon Y, Sriprasart T, Srisawat N, Jutivorakool K, Paitoonpong L, Putcharoen O, Townamchai N.

Abstract:

Link to Article

Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses

Gupta T, Gupta SK.

Abstract:

Link to Article

Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic

Souza IL, Fernandes Í, Taranto P, Buzaid AC, Schvartsman G.

Abstract:

Link to Article

Optical theranostics and treatment dosimetry for COVID-19 lung complications: towards increasing the survival rate of vulnerable populations

Nogueira MS.

Abstract:

Link to Article

Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment

Yeleswaram S, Smith P, Burn T, Covington M, Juvekar A, Li Y, Squier P, Langmuir P.

Abstract:

Link to Article

Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection

Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z.

Abstract:

Link to Article

Convalescent plasma therapy in the treatment of COVID-19: some considerations: correspondence

Wiwanitkit V.

Abstract:

Link to Article

Use of inhaled corticosteroids in asthma and COVID-19 : Keep calm and carry on

Lipworth B, Chan R, RuiWen Kuo C.

Abstract:

Link to Article

Use of aerosolised medications at home for COVID-19

Ari A.

Abstract:

Link to Article

THE RIGHT TIME FOR STEROIDS IN COVID-19

Cruz AF, Ruiz-Antorán B, Múñez Rubio E, López AS, Callejas Díaz A, Avendaño-Solá C, Martínez AR.

Abstract:

Link to Article

[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia]

Hasselbalch HC, Poulsen A, Skov V, Kjær L, Nielsen CH, Poulsen TD.

Abstract:

Link to Article

Clozapine and COVID-19: The authors respond

Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O.

Abstract:

Link to Article

Clozapine and COVID-19

Remington G, Powell V.

Abstract:

Link to Article

A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19

Malek Mahdavi A.

Abstract:

Link to Article

Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis

Recalcati S, Piconi S, Franzetti M, Barbagallo T, Prestinari F, Fantini F.

Abstract:

Link to Article

Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer

Portsmore S, Tran Nguyen TN, Beacham E, Neelakantan P.

Abstract:

Link to Article

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19

Wilson AJ, Troy-Barnes E, Subhan M, Clark F, Gupta R, Fielding AK, Kottaridis P, Mansour MR, O'Nions J, Payne E, Chavda N, Baker R, Thomson K, Khwaja A.

Abstract:

Link to Article

INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY

Olivares-Gazca JC, Priesca-Marín JM, Ojeda-Laguna M, Garces-Eisele J, Soto-Olvera S, Palacios-Alonso A, Izquierdo-Vega J, Chacon-Cano R, Arizpe-Bravo D, López-Trujillo MA, Cantero-Fortiz Y, Fernandez-Lara D, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Abstract:

Link to Article

Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History

Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M.

Abstract:

Link to Article

Response to "Does amantadine have a protective effect against COVID-19?"

Tipton PW, Wszolek ZK.

Abstract:

Link to Article

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S.

Abstract:

Link to Article

Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property

Sriwijitalai W, Wiwanitkit V.

Abstract:

Link to Article

Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline

Abid MA, Nunley L, Abid MB.

Abstract:

Link to Article

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study

Giudice V, Pagliano P, Vatrella A, Masullo A, Poto S, Polverino BM, Gammaldi R, Maglio A, Sellitto C, Vitale C, Serio B, Cuffa B, Borrelli A, Vecchione C, Filippelli A, Selleri C.

Abstract:

Link to Article

Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19

Sestili P, Stocchi V.

Abstract:

Link to Article

Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?

Kazama I.

Abstract:

Link to Article

Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial

Fang B, Zhang W, Wu X, Huang T, Li H, Zheng Y, Che J, Sun S, Jiang C, Zhou S, Feng J.

Abstract:

Link to Article

Evaluation on different non-pharmaceutical interventions during COVID-19 pandemic: an analysis of 139 countries

Wong M, Huang J, Teoh J, Wong S.

Abstract:

Link to Article

Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease

Daunt A, Perez-Guzman PN, Liew F, Hauck K, Costelloe CE, Thursz MR, Cooke G, Nayagam S.

Abstract:

Link to Article

Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic

Hser YI, Mooney LJ.

Abstract:

Link to Article

Clinical pharmacology considerations for developing small molecule treatments for COVID-19

Brunsdon P, Saluja B, Sahajwalla C.

Abstract:

Link to Article

Response to: Can Transdermal Photobiomodulation Help Us at the Time of COVID-19?

Ferreira MVL.

Abstract:

Link to Article

Author's Response to Ferreira: Can Transdermal Photobiomodulation Help Us at the Time of COVID-19? An Update

Camacho AD.

Abstract:

Link to Article

Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

Lucchesi A, Silimbani P, Musuraca G, Cerchione C, Martinelli G, Di Carlo P, Napolitano M.

Abstract:

Link to Article

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial

Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dol

Abstract:

Link to Article

Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?

Rabbani AB, Parikh RV, Rafique AM.

Abstract:

Link to Article

Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets

Nimgampalle M, Devanathan V, Saxena A.

Abstract:

Link to Article

Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia?

Salomaa S, Bouffler SD, Atkinson MJ, Cardis E, Hamada N.

Abstract:

Link to Article

COVID-19 Phenotypes and Potential Harm of Conventional Treatments: How to Prove the Hypothesis

Fowler AJ, Wan YI, Carenzo L, Haines RW.

Abstract:

Link to Article

Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects

Bushell W, Castle R, Williams MA, Brouwer KC, Tanzi RE, Chopra D, Mills PJ.

Abstract:

Link to Article

Treatment of COVID-19 by Inhaled NO to Reduce Shunt?

Hedenstierna G, Chen L, Hedenstierna M, Scaramuzzo G.

Abstract:

Link to Article

Clinical research protocol to evaluate the effectiveness and safety of individualized homeopathic medicine in the treatment and prevention of the COVID-19 epidemic

Teixeira MZ.

Abstract:

Link to Article

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

Osborne V, Davies M, Lane S, Evans A, Denyer J, Dhanda S, Roy D, Shakir S.

Abstract:

Link to Article

G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19

da Rocha J, Othman H, Tiemessen CT, Botha G, Ramsay M, Masimirembwa C, Adebamowo C, Choudhury A, Brandenburg JT, Matshaba M, Simo G, Gamo FJ, Hazelhurst S.

Abstract:

Link to Article

Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19

Rhodes NJ, Dairem A, Moore W, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivek ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT.

Abstract:

Link to Article

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, Zhou N, Petty LA, Baang JH, Dillman NO, Frame D, Gregg KS, Kaul DR, Nagel J, Patel TS, Zhou S, Lauring AS, Hanauer DA, Martin E, Sharma P, Fung CM, Pogue JM.

Abstract:

Link to Article

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes

Benkeser D, Diaz I, Luedtke A, Segal J, Scharfstein D, Rosenblum M.

Abstract:

Link to Article

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

Rosenke K, Jarvis MA, Feldmann F, Schwarz B, Okumura A, Lovaglio J, Saturday G, Hanley PW, Meade-White K, Williamson BN, Hansen F, Perez-Perez L, Leventhal S, Tang-Huau TL, Nason M, Callison J, Haddock E, Scott D, Sewell G, Bosio CM, Hawman D, de Wit E, Feldmann H.

Abstract:

Link to Article

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

Hanson QM, Wilson KM, Shen M, Itkin Z, Eastman RT, Shinn P, Hall MD.

Abstract:

Link to Article

COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies

Khan K, Dimtri F, Vargas C, Surani S.

Abstract:

Link to Article

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches

Lang FM, Lee KM, Teijaro JR, Becher B, Hamilton JA.

Abstract:

Link to Article

DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1

Zhou S, Zhou Z, Ding K, Yuan Y, Loftin C, Zheng F, Zhan CG.

Abstract:

Link to Article

Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

Bodei L, Bergsland EK, de Herder WK, Ferone D, Hicks RJ, Hope TA, Kunikowska JA, Pavel M, Reidy-Lagunes DL, Siveke J, Strosberg JR, Dittmer U, Herrmann K.

Abstract:

Link to Article

Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al

Schulze-Koops H, Krueger K, Specker C; Kommission Pharmakotherapie of the German Society of Rheumatology.

Abstract:

Link to Article

Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint

Mahase E.

Abstract:

Link to Article

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina

Zimman S, Cura MJ, Luna PC, Echeverría CM, Mazzuoccolo LD.

Abstract:

Link to Article

Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

Tahamtan A, Tavakoli-Yaraki M, Salimi V.

Abstract:

Link to Article

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection

Lechowicz K, Drożdżal S, Machaj F, Rosik J, Szostak B, Zegan-Barańska M, Biernawska J, Dabrowski W, Rotter I, Kotfis K.

Abstract:

Link to Article

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients

Subramanian S, Iles T, Ikramuddin S, Steer CJ.

Abstract:

Link to Article

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E.

Abstract:

Link to Article

Making treatment recommendations during the COVID-19 pandemic

Lewin W.

Abstract:

Link to Article

Pirfenidone: A novel hypothetical treatment for COVID-19

Seifirad S.

Abstract:

Link to Article

Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient

Gómez-Enjuto S, Hernando-Requejo V, Lapeña-Motilva J, Ogando-Durán G, Fouz-Ruiz D, Domingo-García J, Rodríguez-García E, Cemillán-Fernández CA.

Abstract:

Link to Article

Discovering small-molecule therapeutics against SARS-CoV-2

Tiwari V, Beer JC, Sankaranarayanan NV, Swanson-Mungerson M, Desai UR.

Abstract:

Link to Article

Current and future therapeutical approaches for COVID-19

Duan Y, Yao Y, Kumar SA, Zhu HL, Chang J.

Abstract:

Link to Article

Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study

Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX.

Abstract:

Link to Article

UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients

Abstract:

Link to Article

Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports

Guo D, Pan S, Wang M, Guo Y.

Abstract:

Link to Article

Hyperbaric oxygen as a treatment for COVID-19 infection?

Moon RD, Weaver LK.

Abstract:

Link to Article

A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on https://doi.

Steinman L.

Abstract:

Link to Article

Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China

Ye YA; G-CHAMPS Collaborative Group.

Abstract:

Link to Article

Case Report: Clinical Treatment of the First Critical Patient With Coronavirus Disease (COVID-19) in Liaocheng, Shandong Province

Tian H, Sui Y, Tian S, Zou X, Xu Z, He H, Wu T.

Abstract:

Link to Article

Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir

Wada T, Shimode K, Hoshiyama T, Takayama Y, Yamaoka K.

Abstract:

Link to Article

Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak

Bonzano C, Borroni D, Lancia A, Bonzano E.

Abstract:

Link to Article

New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention

Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, Chen Z, Ding N, Li W, Huang H, Zhang L, Li X, Xue X.

Abstract:

Link to Article

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections

Chrzanowski W, Kim SY, McClements L.

Abstract:

Link to Article

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review

Prayuenyong P, Kasbekar AV, Baguley DM.

Abstract:

Link to Article

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals

Yang C, Ke C, Yue D, Li W, Hu Z, Liu W, Hu S, Wang S, Liu J.

Abstract:

Link to Article

COVID-19: Emergence, Spread, Possible Treatments, and Global Burden

Keni R, Alexander A, Nayak PG, Mudgal J, Nandakumar K.

Abstract:

Link to Article

Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic

Baud D, Dimopoulou Agri V, Gibson GR, Reid G, Giannoni E.

Abstract:

Link to Article

Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?

Mary A, Hénaut L, Schmit JL, Lanoix JP, Brazier M.

Abstract:

Link to Article

Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?

Khalil A, Kamar A, Nemer G.

Abstract:

Link to Article

Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?

Murck H.

Abstract:

Link to Article

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P.

Abstract:

Link to Article

Interferon-α2b Treatment for COVID-19

Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN.

Abstract:

Link to Article

The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

Murray AK.

Abstract:

Link to Article

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?

Sisay M.

Abstract:

Link to Article

Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine

Qiu R, Zhao C, Liang T, Hao X, Huang Y, Zhang X, Chen Z, Wei X, Zhao M, Zhong C, Hu J, Li M, Han S, He T, Sun Y, Chen J, Shang H.

Abstract:

Link to Article

COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology

Egger A, Abrouk M, Brodsky M, Kirsner RS.

Abstract:

Link to Article

Considerations of Managing Lichen Planopilaris With Hydroxychloroquine During the COVID-19 Pandemic

Dadkhahfar S, Araghi F, Tabary M, Moravvej H.

Abstract:

Link to Article

Heart Transplant Recipient Patient with COVID-19 Treated with Tocilizumab

Mattioli M, Fustini E, Gennarini S.

Abstract:

Link to Article

COVID-19: From pathogenesis models to the first drug trials

Brüssow H.

Abstract:

Link to Article

Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion

Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B, Li J, Wang Z, Wu W, Wu M, Li W, Li L, Cai Y, Bosco B, Zhong A, Liu X, Lv T, Gan Z, Chen G, Pan Y, Liu C, Zhang K, Xu X, Wang C, Wang Q.

Abstract:

Link to Article

[Drug treatment of coronavirus disease COVID-19: evidence exists?]

Timerbulatov SV, Timerbulstov MV, Gainullina EN, Gafarova AR, Timerbulatov VM.

Abstract:

Link to Article

Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient

Alvarez JC, Moine P, Etting I, Annane D, Larabi IA.

Abstract:

Link to Article

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

Klasse PJ, Moore JP.

Abstract:

Link to Article

Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration

Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, Bozgan AM, Gendrin V, Charpentier A, Toko L, Badie J, Mezher C, Roux MF, Kadiane-Oussou NJ, Contreras R, Kessler J, Mazurier I, Klopfenstein T, Zayet S.

Abstract:

Link to Article

Management of chronic rhinosinusitis with steroid nasal irrigations: a viable non-surgical alternative in the COVID-19 Era

Sweis AM, Locke TB, Douglas JE, Lin TC, Sweis BM, Civantos AM, Kennedy DW.

Abstract:

Link to Article

The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance

Tuccori M, Convertino I, Ferraro S, Cappello E, Valdiserra G, Focosi D, Blandizzi C.

Abstract:

Link to Article

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Yu B, Li C, Chen P, Zhou N, Wang L, Li J, Jiang H, Wang DW.

Abstract:

Link to Article

[Remdesivir for patients with COVID-19]

Augustin M, Hallek M, Nitschmann S.

Abstract:

Link to Article

Literature-based review of the drugs used for the treatment of COVID-19

Venkatasubbaiah M, Dwarakanadha Reddy P, Satyanarayana SV.

Abstract:

Link to Article